Processing 00000000.tx.1: Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells Yue-Jin Wen, Bart Barlogie, and Qing Yi From the Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, AR.  

Phrase: "Idiotype-specific cytotoxic T lymphocytes in multiple myeloma"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0039195:Cytotoxic T-Lymphocytes [Cell]
   770   C0039194:T-Lymphocytes [Cell]
   744   C0024264:Lymphocytes [Cell]
   744   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   744   C1511636:cytotoxic [Functional Concept]

Phrase: ":"

Phrase: "evidence for their capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "to"

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "autologous primary tumor cells Yue-Jin Wen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0014511:Wen [Anatomical Abnormality]
   795   C0086809:Wen [Anatomical Abnormality]
   795   C1547963:Wen [Intellectual Product]

Phrase: "Bart Barlogie,"

Phrase: "and"

Phrase: "Qing Yi From the Myeloma"

Phrase: "and"

Phrase: "Transplantation Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "University of Arkansas for Medical Sciences,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0025118:medical sciences [Biomedical Occupation or Discipline]
   799   C0003790:Arkansas [Geographic Area]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205476:Medical [Functional Concept]
   799   C1551966:Arkansas [Language]

Phrase: "Little Rock,"

Phrase: "AR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986463:AR+ [Finding]
Processing 00000000.tx.2: Abstract Top Abstract Introduction Materials and methods Results Discussion References Multiple myeloma (MM) is a B-cell malignancy. 

Phrase: "Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Multiple myeloma (MM)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "is"

Phrase: "a B-cell malignancy."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0006826:Malignancy [Neoplastic Process]
   827   C1306459:Malignancy [Finding]
   755 E C0205282:Malignant [Qualitative Concept]
   755 E C0334590:MALIGNANT [Neoplastic Process]
   755 E C1533592:MALIGNANT [Neoplastic Process]
   734   C0004561:B-cell [Cell]
Processing 00000000.tx.3: The monoclonal immunoglobulin, secreted by myeloma plasma cells, carries unique antigenic determinants (idiotype [Id]) that can be regarded as a tumor-specific antigen. 

Phrase: "The monoclonal immunoglobulin,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0443737:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0700271:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]
   861   C1621846:immunoglobulin [Molecular Function]

Phrase: "secreted by myeloma plasma cells,"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   827   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
           Myeloma
   806   C0032112:Plasma Cells [Cell]
   797   C0333843:cells myeloma [Cell]
   760   C0007634:Cells [Cell]
   760   C0032105:Plasma [Body Substance]
   760   C1327616:Secreted [Cell Function]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C3282337:Cells [Cell]
   760   C3538749:Myeloma [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "unique antigenic determinants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003316:Antigenic Determinants [Immunologic Factor]
   793   C1521761:Determinant [Functional Concept]
   755   C0003320:Antigen [Immunologic Factor]
   755   C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(idiotype [Id]"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "regarded as a tumor-specific antigen."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0041361:tumor-specific antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumor antigen
   790   C0456981:Specific antigen [Immunologic Factor]
   753   C0003320:Antigen [Immunologic Factor]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
Processing 00000000.tx.4: Id-based immunotherapy has been explored in myeloma patients for the purpose of enhancing or inducing Id-specific immune responses that might lead to tumor destruction. 

Phrase: "Id-based immunotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021083:Immunotherapy [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "explored in myeloma patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026764:Myeloma [Neoplastic Process]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3538749:Myeloma [Intellectual Product]

Phrase: "for the purpose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1285529:Purpose [Functional Concept]

Phrase: "of enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "or"

Phrase: "inducing Id-specific immune responses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C0683201:Specific immune response [Organ or Tissue Function]
   840   C0301872:immune responses [Organ or Tissue Function]
   804   C0439662:Immune [Functional Concept]
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]

Phrase: "that"

Phrase: "might"

Phrase: "lead to tumor destruction."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1446301:Tumor destruction [Therapeutic or Preventive Procedure]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0027651:Tumor [Neoplastic Process]
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1948029:Destruction [Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3273930:Tumor [Finding]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.5: However, despite some evidence obtained from mouse plasmacytoma models, it is still unclear whether Id-specific immunity may play a role in the regulation of tumor cells in MM. 

Phrase: "However,"

Phrase: "despite some evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "obtained from mouse plasmacytoma models,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C1522685:Mouse Plasmacytoma [Neoplastic Process]
   781   C2986594:Mouse Model [Experimental Model of Disease]
   760   C0025914:Mouse [Mammal]
   760   C0025929:mouse [Mammal]
   760   C0026809:Mouse [Mammal]
   760   C0032131:Plasmacytoma [Neoplastic Process]
   760   C1301820:Obtained [Functional Concept]
   760   C3161035:Models [Intellectual Product]
   726 E C1706701:Obtain [Activity]
   704 E C1136084:PLASMA CELL TUMOR [Neoplastic Process]
   704 E C1959632:Plasma Cell Tumor [Neoplastic Process]

Phrase: "it"

Phrase: "is"

Phrase: "still unclear"

Phrase: "whether"

Phrase: "Id-specific immunity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0683201:specific immunity [Organ or Tissue Function]
   827   C0020964:Immunity [Physiologic Function]
   755 E C0439662:Immune [Functional Concept]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the regulation of tumor cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.6: In the current study, using dendritic cells (DCs) as antigen-presenting cells, autologous Id-specific cytotoxic T lymphocyte (CTL) lines containing both CD4+ and CD8+ T cells were generated from myeloma patients. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dendritic cells (DCs) as antigen-presenting cells,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   846   C0003315:Antigen-presenting dendritic cell [Cell]
       E   Dendritic cell
   790   C0011306:Dendritic Cells [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "autologous Id-specific cytotoxic T lymphocyte (CTL) lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   877   C0677856:Autologous Lymphocyte [Cell]
   845   C0039195:Cytotoxic T lymphocyte [Cell]
   818   C0039194:T-Lymphocyte [Cell]
   795   C0024264:Lymphocyte [Cell]
   795   C0205132:lines [Spatial Concept]
   795   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   795   C1511636:cytotoxic [Functional Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "both CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8+ T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "generated from myeloma patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026764:Myeloma [Neoplastic Process]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]
   770   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.7: The results show that Id-specific CTLs not only recognized and lysed autologous Id-pulsed DCs but also significantly killed the autologous primary myeloma cells. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "recognized"

Phrase: "and"

Phrase: "lysed autologous Id-pulsed DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   885   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   827   C0011306:Dendritic Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0011305:Dendritic [Cell Component]
   799   C0439640:Dendritic [Qualitative Concept]
   799   C3282337:Cells [Cell]
   793 E C0003315:Dendritic cell [Cell]
   793 E C1511762:Dendritic Cell [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "also significantly"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "the autologous primary myeloma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0333843:Myeloma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0026764:Myeloma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   812   C3538749:Myeloma [Intellectual Product]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: The cytotoxicity against the primary tumor cells was major histocompatibility complex (MHC) class I- and, to a lesser extent, class II-restricted, indicating that myeloma cells could process Id protein and present Id peptides in the context of their surface MHC molecules. 

Phrase: "The cytotoxicity against the primary tumor cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   721   C0022686:Cytotoxic cell [Cell]

Phrase: "was"

Phrase: "major histocompatibility complex (MHC) class I-"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "class II-restricted,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0443288:Restricted [Functional Concept]
   734   C0441886:Class II [Intellectual Product]
   734   C2698968:Class II [Finding]

Phrase: "indicating"

Phrase: "that myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "process Id protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0033666:process protein [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "present Id peptides in the context of their surface MHC molecules."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C0030956:Peptides [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.9: Furthermore, the CTLs lysed the target cells mainly through the perforin-mediated pathway because Concanamycin A, but not BrefeldinAthe selective inhibitors for perforin- or Fas-mediated pathwaysabrogated the cytolytic activity of the cells. 

Phrase: "Furthermore,"

Phrase: "the CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "the target cells mainly through the perforin-mediated pathway"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0221284:Target cells [Cell]
   764   C3272919:Target Cells [Laboratory Procedure]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "Concanamycin A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056224:concanamycin A [Antibiotic,Organic Chemical]

Phrase: "but"

Phrase: "not BrefeldinAthe selective inhibitors for perforin-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "Fas-"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "pathwaysabrogated"

Phrase: "the cytolytic activity of the cells."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.10: These CTLs secreted predominantly interferon- and tumor necrosis factor- on antigen stimulation, indicating that they belong to the type-1 T-cell subsets. 

Phrase: "These CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "secreted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secreted [Cell Function]

Phrase: "predominantly interferon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "on antigen stimulation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "indicating"

Phrase: "that"

Phrase: "they"

Phrase: "belong to the type-1 T-cell subsets."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   800   C0080202:T-Cell Subsets [Cell]
   800   C2362651:T cell subsets [Finding]
   770   C0039194:T-cell [Cell]
   770   C0441729:Type 1 [Classification]
   767   C0007634:Cell Type [Cell]
           Cell
   767   C0449475:cell type [Intellectual Product]
   744   C0332307:Type [Qualitative Concept]
   744   C1269647:Cell [Cell]
   744   C1547052:*Type [Quantitative Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   711   C1515021:Subset [Classification]
Processing 00000000.tx.11: Taken together, these findings represent the first demonstration that Id-specific CTLs are able to lyse autologous tumor cells in MM and, thus, provide a rationale for Id-based immunotherapy in the disease. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the first demonstration"

Phrase: "that Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "are"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "autologous tumor cells in MM"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C1510985:Autologous Tumor Cells [Cell]
   790   C0431085:Tumor cells [Cell]
   783   C0333843:cells myeloma [Cell]
   756 E C0597032:Tumor Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0439859:Autologous [Qualitative Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: ","

Phrase: "thus,"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "a rationale for Id-based immunotherapy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392360:Rationale [Idea or Concept]
   753   C2699007:Rationale [Idea or Concept]

Phrase: "in the disease."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.12: (Blood. 

Phrase: "(Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.13: 2001;97:1750-1755)  2001 by The American Society of Hematology.  

Phrase: "2001"

Phrase: ";97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "1750-1755"

Phrase: ")"

Phrase: "2001 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]
Processing 00000000.tx.14: Introduction Top Abstract Introduction Materials and methods Results Discussion References Multiple myeloma (MM) is a B-cell malignancy that accounts for 1% of all cancers and 10% of all hematologic malignancies. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "(MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "a B-cell malignancy"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0006826:Malignancy [Neoplastic Process]
   827   C1306459:Malignancy [Finding]
   755 E C0205282:Malignant [Qualitative Concept]
   755 E C0334590:MALIGNANT [Neoplastic Process]
   755 E C1533592:MALIGNANT [Neoplastic Process]
   734   C0004561:B-cell [Cell]

Phrase: "that accounts for 1% of all cancers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1551359:account [Idea or Concept]
   714   C2741673:Account # [Clinical Attribute]
   714   C2981730:Account [Classification]

Phrase: "and"

Phrase: "10% of all hematologic malignancies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0376545:Hematologic Malignancies [Neoplastic Process]
   760   C0006826:MALIGNANCIES [Neoplastic Process]
   760   C0018943:Hematologic [Biomedical Occupation or Discipline]
   760   C0205488:Haematologic [Functional Concept]
   726 E C1306459:Malignancy [Finding]
Processing 00000000.tx.15: With conventional chemotherapy, complete remission rates have not exceeded 5%, and median survival has not been extended beyond 3years.1,2 High-dose chemotherapy followed by stem cell support results in long-term, disease-free survival in one third of myeloma patients.3 However, relapse of the underlying disease remains the primary cause of treatment failure.4 Therefore, novel alternative therapeutic strategies aiming at improved outcome in these patients are much needed. 

Phrase: "With conventional chemotherapy,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0013217:chemotherapy [Functional Concept]
   861   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   861   C0439858:Conventional [Qualitative Concept]
   789 E C0086047:convention [Human-caused Phenomenon or Process]

Phrase: "complete remission rates"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C0677874:Complete Remission [Finding]
   827   C0205197:Complete [Qualitative Concept]
   827   C0544452:Remission [Finding]
   827   C0687702:remission [Neoplastic Process]
   827   C0725685:COMPLEAT [Food]
   793   C0871208:Rate [Activity]
   793   C1521828:Rate [Quantitative Concept]
   755 E C0439812:Completeness [Qualitative Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exceeded"

Phrase: "5%,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "median survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "extended beyond 3years.1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]

Phrase: "2 High-dose chemotherapy"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C1328050:high-dose chemotherapy [Therapeutic or Preventive Procedure]
   861   C0444956:High dose [Quantitative Concept]
   812   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   812   C0013217:chemotherapy [Functional Concept]
   812   C0178602:Dose [Quantitative Concept]
   812   C0205250:High [Qualitative Concept]
   812   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
   812   C0869039:Dose [Quantitative Concept]
   812   C1114758:Dose # [Clinical Attribute]
   812   C1299351:High [Qualitative Concept]
   812   C2700149:HIGH [Intellectual Product]

Phrase: "followed by stem cell support results"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   790   C0038250:Stem cell [Cell]
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0007634:Cell [Cell]
   753   C0183683:Support [Medical Device]
   753   C0242767:Stem [Plant]
   753   C1186763:Stem [Body Part, Organ, or Organ Component]
   753   C1269647:Cell [Cell]
   753   C1521721:Support [Conceptual Entity]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719 E C1719822:Follow [Intellectual Product]
   719   C2825142:Result [Finding]

Phrase: "in long-term, disease-free survival"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   884   C0242793:Disease-Free Survival [Quantitative Concept]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0038952:Survival [Activity]
   804   C0220921:survival [Functional Concept]
   804   C0332296:free [Functional Concept]
   804   C1880497:Free [Qualitative Concept]
   804   C1996904:Free [Qualitative Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "in one third"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "of myeloma patients.3 However,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0026764:Myeloma [Neoplastic Process]
   812   C0030705:Patients [Patient or Disabled Group]
   812   C3538749:Myeloma [Intellectual Product]

Phrase: "relapse of the underlying disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0277556:DISEASE RELAPSE [Disease or Syndrome]
           Relapse
   760   C0035020:Relapse [Phenomenon or Process]
   760   C0205336:relapse [Temporal Concept]

Phrase: "remains"

Phrase: "the primary cause of treatment failure.4 Therefore,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C1708063:primary treatment [Therapeutic or Preventive Procedure]
   744   C0015127:cause [Functional Concept]
   744   C0205225:Primary [Qualitative Concept]
   744   C0439631:Primary [Therapeutic or Preventive Procedure]
   744   C1524003:Cause [Conceptual Entity]

Phrase: "novel alternative therapeutic strategies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0679199:strategies [Mental Process]

Phrase: "aiming at improved outcome"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0184511:Improved [Qualitative Concept]
   770   C0332272:Improved [Qualitative Concept]
   770   C1274040:Outcome [Functional Concept]
   770   C1561611:Improved [Intellectual Product]
   737   C1947946:Aim [Idea or Concept]
   737   C2948600:Aim [Pharmacologic Substance]
   737   C3540471:AIM [Gene or Genome]
   737   C3540472:AIM [Functional Concept]

Phrase: "in these patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "are"

Phrase: "much"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.16: Tumor vaccines based either on immunization against specific tumor antigens or on adoptive transfer of ex vivo-generated lymphocytes, with high levels of specific reactivity against tumor antigens, represent attractive approaches.5-8 In MM, the idiotype (Id) determinant of the paraprotein can be regarded as a tumor-specific marker and has been used for immunotherapy of MM.9-14 Although modest and transient, Id-specific immune responses can be induced in 25% to 100% of these patients. 

Phrase: "Tumor vaccines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0376659:Vaccines, Tumor [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   827 E C1552558:Vaccine [Intellectual Product]

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "either on immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   790   C0042196:immunisation [Therapeutic or Preventive Procedure]
   790   C3244291:immunization [Functional Concept]

Phrase: "against specific tumor antigens"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   913   C0456981:Specific antigens [Immunologic Factor]
   901   C0041361:Tumor Antigens [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003320:Antigens [Immunologic Factor]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1578706:Tumor [Intellectual Product]
   827   C3273930:Tumor [Finding]
   721 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "or on adoptive transfer of ex vivo-generated lymphocytes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0376518:Adoptive Transfer [Therapeutic or Preventive Procedure]
   764   C2348480:ex vivo [Functional Concept]
   742   C0024264:Lymphocytes [Cell]
   742   C0040671:Transfer [Mental Process]
   742   C1515655:vivo [Spatial Concept]
   742   C1705822:Transfer [Activity]
   742   C3146294:Generated [Activity]

Phrase: "with high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of specific reactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0205332:Reactive [Qualitative Concept]

Phrase: "against tumor antigens,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0041361:Tumor Antigens [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "attractive approaches.5-8 In MM,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   748   C0439064:Multiple [Quantitative Concept]
   748   C0449445:Approaches [Spatial Concept]
   748   C1292724:Approaches [Functional Concept]
   748   C2346874:Attractive [Qualitative Concept]
   748   C3538749:Myeloma [Intellectual Product]

Phrase: "the idiotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")"

Phrase: "determinant of the paraprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521761:Determinant [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "regarded as a tumor-specific marker"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0041365:Tumor Marker [Biologically Active Substance]
   753   C0005516:Marker [Clinical Attribute]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "used for immunotherapy of MM.9-14"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   750   C1524063:Use of [Functional Concept]
   744   C0021083:Immunotherapy [Therapeutic or Preventive Procedure]
   744   C0439064:Multiple [Quantitative Concept]
   744   C1273517:used [Finding]
   744   C3538749:Myeloma [Intellectual Product]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "Although"

Phrase: "modest"

Phrase: "and"

Phrase: "transient, Id-specific immune responses"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   867   C0683201:Specific immune response [Organ or Tissue Function]
   840   C0301872:immune responses [Organ or Tissue Function]
   804   C0439662:Immune [Functional Concept]
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]

Phrase: "can"

Phrase: "be"

Phrase: "induced in 25%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205263:Induced [Functional Concept]

Phrase: "to 100%"

Phrase: "of these patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.17: However, clinical responses, defined by a significant reduction in M components, have been observed in few patients after Id vaccination.11,13 Thus, the role of Id-specific immune responses in the regulation of tumor cell growth is poorly understood, and, more important, whether Id-specific cytotoxic T lymphocytes (CTLs) lyse the primary myeloma cells has not been demonstrated in MM. 

Phrase: "However,"

Phrase: "clinical responses,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "defined by a significant reduction"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0237881:significant [Quantitative Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "in M components,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0027015:M Components [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0030490:M component [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C0449432:Components [Manufactured Object]
   827 E C1705248:Component [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "observed in few patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "after Id vaccination.11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "13 Thus,"

Phrase: "the role of Id-specific immune responses"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of tumor cell growth"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0598934:tumor growth [Neoplastic Process]
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   734   C0431085:Tumor cell [Cell]
   734   C0597032:Tumor Cell [Cell]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: ","

Phrase: "and"

Phrase: ","

Phrase: "more important,"

Phrase: "whether"

Phrase: "Id-specific cytotoxic T lymphocytes (CTLs)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "the primary myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0333843:Myeloma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0026764:Myeloma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   827   C3538749:Myeloma [Intellectual Product]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "demonstrated in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   770   C0439064:Multiple [Quantitative Concept]
   770   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.18: It is still unclear whether the induced/enhanced Id-specific immune response after immunization is relevant to or responsible for the clinical response observed in patients. 

Phrase: "It"

Phrase: "is"

Phrase: "still unclear"

Phrase: "whether"

Phrase: "the induced/enhanced Id-specific immune response after immunization"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0683201:Specific immune response [Organ or Tissue Function]
   764   C0301872:Immune response [Organ or Tissue Function]
   742   C0439662:Immune [Functional Concept]
   742   C0871261:Response [Organism Attribute]
   742   C1704632:Response [Finding]
   742   C1706817:Response [Intellectual Product]
   742   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "relevant to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2347946:Relevant [Qualitative Concept]

Phrase: "or"

Phrase: "responsible for the clinical response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "observed in patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1441672:Observed [Functional Concept]
Processing 00000000.tx.19: The objectives of this study were to generate Id-specific CTLs from myeloma patients and to examine the efficacy of these T cells in lysis of their target cells, including Id-pulsed dendritic cells (DCs) and autologous primary myeloma cells. 

Phrase: "The objectives of this study"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C2985627:Study Objective [Idea or Concept]
   760   C0018017:objectives [Intellectual Product]
   726 E C1571702:Objective [Qualitative Concept]

Phrase: "were"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "Id-specific CTLs from myeloma patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0039195:Cytotoxic T-Lymphocytes [Cell]
   770   C0039194:T-Lymphocytes [Cell]
   744   C0024264:Lymphocytes [Cell]
   744   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   744   C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the efficacy of these T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:Efficacy [Qualitative Concept]
   753   C1707887:EFFICACY [Research Activity]

Phrase: "in lysis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0024348:Lysis [Pathologic Function]
  1000   C1536403:lysis [Cell Function]
   928 E C0439680:Lytic [Qualitative Concept]

Phrase: "of their target cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Id-pulsed dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "autologous primary myeloma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0333843:Myeloma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0026764:Myeloma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   812   C3538749:Myeloma [Intellectual Product]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.20: Id-specific CTLs were generated by using autologous adherent peripheral blood mononuclear cell-derived DCs as antigen-presenting cells (APCs). 

Phrase: "Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "were"

Phrase: "generated by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "autologous adherent peripheral blood mononuclear cell-derived DCs"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   895   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   877   C1321301:Peripheral Blood Mononuclear Cells [Cell]
           Peripheral blood mononuclear cell (cell)
   854   C0005773:Blood Cells [Cell]
   842   C0806987:Mononuclear cells [Cell]
   807   C0011306:Dendritic Cells [Cell]
   791   C0007634:Cells [Cell]
   791   C0011305:Dendritic [Cell Component]
   791   C0439640:Dendritic [Qualitative Concept]
   791   C3282337:Cells [Cell]
   774 E C0003315:Dendritic cell [Cell]
   774 E C1511762:Dendritic Cell [Cell]

Phrase: "as antigen-presenting cells (APCs)."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.21: We show for the first time that Id-pulsed DCs reproducibly led to successful in vitro generation of Id-specific CTLs capable of killing the autologous primary myeloma cells.  

Phrase: "We"

Phrase: "show for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1547282:Show [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that Id-pulsed DCs reproducibly"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "led to successful in vitro generation of Id-specific CTLs"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   770   C0039195:Cytotoxic T-Lymphocytes [Cell]
   753   C0021135:In Vitro [Intellectual Product]
   753   C0039194:T-Lymphocytes [Cell]
   753   C1533691:in vitro [Qualitative Concept]
           vitro
   753   C2827718:In Vitro [Functional Concept]
   736   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0024264:Lymphocytes [Cell]
   736   C0079411:Generation [Temporal Concept]
   736   C0205369:Specific [Qualitative Concept]
   736   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   736   C1272703:Successful [Qualitative Concept]
   736   C1511636:cytotoxic [Functional Concept]
   736   C1552740:specific [Intellectual Product]
   736   C1708698:LED [Manufactured Object]
   736   C3146294:Generation [Activity]
   703 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   703 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   703 E C1522538:Lead [Functional Concept]
   703 E C2348269:Lead [Element, Ion, or Isotope]
   703 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "the autologous primary myeloma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0333843:Myeloma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0026764:Myeloma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   812   C3538749:Myeloma [Intellectual Product]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.22: Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Isolation of idiotype protein Affinity chromatography column prepared with anti-human IgA (-chain specific) monoclonal antibody-conjugated agarose (A2691; Sigma, St Louis, MO) was used to isolate and purify IgA Id protein from serum obtained from a patient with IgA myeloma. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Isolation of idiotype protein Affinity chromatography column"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0204727:Isolation [Therapeutic or Preventive Procedure]
   748   C0205409:Isolation [Functional Concept]
   748   C0220862:isolation [Laboratory Procedure]

Phrase: "prepared with anti-human IgA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C2825347:Human IgA [Immunologic Factor,Pharmacologic Substance]
           IgA
   797   C0051976:anti-IgA [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0086418:Human [Human]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(-chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337112:Chain [Manufactured Object]
  1000   C1524075:Chain [Idea or Concept]

Phrase: "specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: ")"

Phrase: "monoclonal antibody-conjugated agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0036681:Agarose [Carbohydrate]

Phrase: "(A2691"

Phrase: "; Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "IgA Id protein from serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0036825:Serum protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1304893:Protein.serum [Laboratory or Test Result]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "obtained from a patient"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0030705:*^patient [Patient or Disabled Group]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "with IgA myeloma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0563305:IgA myeloma [Neoplastic Process]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.23: A Hi-Trap affinity column packed with 1mL Protein-G Sepharose High Performance (both Amersham Pharmacia Biotech AB, Uppsala, Sweden) was used to isolate and purify IgG Id protein from the serum of another patient with IgG myeloma. 

Phrase: "A Hi-Trap affinity column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1185738:Column [Body Part, Organ, or Organ Component]
   812   C1706132:Column [Idea or Concept]

Phrase: "packed with 1mL Protein-G Sepharose"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0060916:protein g [Amino Acid, Peptide, or Protein]
   783 E C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0184967:Packed [Therapeutic or Preventive Procedure]
   753   C0439267:g% [Quantitative Concept]
   719 E C1968515:Pack [Medical Device]
   719 E C2825051:Pack [Drug Delivery Device]
   719 E C2828395:Pack [Activity]

Phrase: "High Performance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205250:High [Qualitative Concept]
   861   C0597198:Performance [Individual Behavior]
   861   C1299351:High [Qualitative Concept]
   861   C1882330:Performance [Activity]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "("

Phrase: "both Amersham Pharmacia Biotech AB,"

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370215:Isolate [Substance]
  1000   C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "purify"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   916   C1947930:Cleanse [Activity]
   916   C1998793:Purified [Functional Concept]

Phrase: "IgG Id protein from the serum of another patient"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C0036825:Serum protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1304893:Protein.serum [Laboratory or Test Result]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with IgG myeloma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0563306:IgG myeloma [Neoplastic Process]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.24: The protein purity was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 

Phrase: "The protein purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1882508:Purity [Quantitative Concept]
   789 E C2247561:PurE [Molecular Function]

Phrase: "was"

Phrase: "determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis."
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   909   C0600209:Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis [Laboratory Procedure,Research Activity]
   800   C0013862:Polyacrylamide Gel Electrophoresis [Laboratory Procedure]
   800   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   770   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   770   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   770   C0596607:Gel Electrophoresis [Laboratory Procedure]
   767   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   767 E C0972569:Electrophoresis Gel [Indicator, Reagent, or Diagnostic Aid]
   744   C0013855:Electrophoresis [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   744   C0038720:Sulfate [Inorganic Chemical]
   744   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   744   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   744   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1382104:Gel [Substance]
   744   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.25: Isoelectric focusing estimated that more than 90% of the purified IgG or IgA was monoclonal. 

Phrase: "Isoelectric focusing"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0022169:Isoelectric Focusing [Laboratory Procedure]
   861   C0000936:focusing [Clinical Attribute]
   861   C2981153:Focusing [Finding]
   827 E C0205234:Focus [Spatial Concept]
   827 E C1285542:focus [Functional Concept]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "that more than 90% of the purified IgG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0439083:>90 [Quantitative Concept]
   744   C0439087:<90 [Quantitative Concept]
   744   C1998793:Purified [Functional Concept]

Phrase: "or"

Phrase: "IgA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825347:IgA [Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "monoclonal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]
Processing 00000000.tx.26: Isolation of primary myeloma plasma cells Fresh bone marrow aspirates from 2patients with advanced MM were collected, and bone marrow mononuclear cells (BMMCs) were separated using Ficoll-Hypaque (Amersham Pharmacia Biotech AB) density centrifugation. 

Phrase: "Isolation of primary myeloma plasma cells Fresh bone marrow aspirates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0007616:cells isolation [Laboratory Procedure]
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "from 2patients"

Phrase: "with advanced MM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   827   C0439064:Multiple [Quantitative Concept]
   827   C3538749:Myeloma [Intellectual Product]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "bone marrow mononuclear cells (BMMCs)"
Meta Candidates (Total=23; Excluded=9; Pruned=0; Remaining=14)
   923   C0005955:Bone Marrow Cells [Cell]
   902   C0222677:Bone cells [Cell]
   886 E C0029432:Bone cell [Cell]
   861   C0005953:Bone Marrow [Tissue]
   861   C0806987:Mononuclear cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0086590:Marrow [Food]
   812   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   812   C0376152:Marrow [Body Part, Organ, or Organ Component]
   812   C0391978:Bone [Tissue]
   812   C1266908:Bone [Body Part, Organ, or Organ Component]
   812   C1266909:Bone [Body System]
   812   C1513475:Mononuclear [Clinical Attribute]
   812   C1546708:Marrow [Intellectual Product]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   756 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   756 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   756 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   741 E C0443157:Bony [Functional Concept]
   729 E C0330477:Marrows [Plant]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ficoll-Hypaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813724:Hypaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Amersham Pharmacia Biotech AB) density centrifugation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0007703:Centrifugation [Laboratory Procedure]
Processing 00000000.tx.27: The BMMCs from the 2patients contained more than 95% CD138+CD38++ myeloma plasma cells, determined by flow cytometry analysis. 

Phrase: "The BMMCs from the 2patients"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   793   C0005955:Bone Marrow Cells [Cell]
   770   C0005953:Bone Marrow [Tissue]
   770   C0806987:Mononuclear cells [Cell]
   767   C0222677:Bone cells [Cell]
   750   C0007634:THE CELL [Cell]
           Cells
   750 E C0029432:Bone cell [Cell]
   744   C0086590:Marrow [Food]
   744   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   744   C0376152:Marrow [Body Part, Organ, or Organ Component]
   744   C0391978:Bone [Tissue]
   744   C1266908:Bone [Body Part, Organ, or Organ Component]
   744   C1266909:Bone [Body System]
   744   C1513475:Mononuclear [Clinical Attribute]
   744   C1546708:Marrow [Intellectual Product]
   744   C3282337:Cells [Cell]
   739 E C1708973:Medullary Bone [Tissue]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "more than 95% CD138+CD38++ myeloma plasma cells,"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   789   C1979010:Cells.CD38+CD138+ [Cell]
   776   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
           Myeloma
   770   C0032112:Plasma Cells [Cell]
   767   C0333843:cells myeloma [Cell]
   767   C0945928:Cells.CD38 [Cell]
   767   C1440255:Cells.CD138 [Cell]
   744   C0007634:Cells [Cell]
   744   C0032105:Plasma [Body Substance]
   744   C0205172:More [Functional Concept]
   744   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   744   C3273112:CD138 [Gene or Genome]
   744   C3282337:Cells [Cell]
   744   C3538749:Myeloma [Intellectual Product]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "determined by flow cytometry analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.28: Aliquots of BMMCs were cryopreserved in 80C until use. 

Phrase: "Aliquots of BMMCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "cryopreserved in 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010405:Cryopreserved [Laboratory Procedure]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.29: Generation of dendritic cells Peripheral blood mononuclear cells (PBMCs) from the same 2patients were isolated from leukapheresis-collected blood cells using Ficoll-Hypaque (Amersham Pharmacia Biotech AB) gradient centrifugation. 

Phrase: "Generation of dendritic cells Peripheral blood mononuclear cells (PBMCs)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079411:Generation [Temporal Concept]
   744   C3146294:Generation [Activity]

Phrase: "from the same 2patients"

Phrase: "were"

Phrase: "isolated from leukapheresis-collected blood cells"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   790   C0005773:Blood Cells [Cell]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0007634:Cells [Cell]
   753   C0023416:Leucapheresis [Therapeutic or Preventive Procedure]
   753   C0205409:Isolated [Functional Concept]
   753   C0229664:Blood [Body Substance]
   753   C1516695:Collected [Idea or Concept]
   753   C1516698:Collected [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   753   C3282337:Cells [Cell]
   745 E C2328697:Hemal cell [Cell]
   719 E C0370215:Isolate [Substance]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1875400:ISOLATE [Pharmacologic Substance]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ficoll-Hypaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813724:Hypaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Amersham Pharmacia Biotech AB) gradient centrifugation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0007703:Centrifugation [Laboratory Procedure]
Processing 00000000.tx.30: Aliquots of PBMCs were cryopreserved in 80C until use. 

Phrase: "Aliquots of PBMCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1510844:Aliquot [Quantitative Concept]
   716   C1321301:Peripheral Blood Mononuclear Cells [Cell]

Phrase: "were"

Phrase: "cryopreserved in 80C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0010405:Cryopreserved [Laboratory Procedure]

Phrase: "until use."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]
Processing 00000000.tx.31: The cryopreserved PBMCs were recovered and resuspended at 5106 cells/mL in RPMI 1640supplemented with 10% fetal calf serum, 1mM glutamine, 100U/mL penicillin, and 100g/mL streptomycin (referred to as complete medium) (Gibco, Grand Island, NY). 

Phrase: "The cryopreserved PBMCs"
Meta Candidates (Total=25; Excluded=12; Pruned=0; Remaining=13)
   937   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   881   C1511548:Cryopreserved Cell [Cell]
   872   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   840   C0229664:peripheral blood [Body Substance]
           Blood
   840   C0806987:Mononuclear cells [Cell]
   808 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0007634:Cells [Cell]
   804   C0205100:Peripheral [Spatial Concept]
   804   C1513475:Mononuclear [Clinical Attribute]
   804   C3282337:Cells [Cell]
   798 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "and"

Phrase: "resuspended at 5106 cells/mL"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C2699156:Cells/mL [Quantitative Concept]
   760   C0007634:Cells [Cell]
   760   C0439526:/mL [Quantitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "in RPMI 1640supplemented"

Phrase: "with 10% fetal calf serum,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "1mM glutamine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017797:Glutamine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "100U/mL penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100g/mL streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "("

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "complete medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: ")"

Phrase: "(Gibco,"

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.32: PBMCs were incubated in a humidified incubator at 37C in 5% CO2 for 2hours to allow cell adhesion. 

Phrase: "PBMCs"
Meta Candidates (Total=24; Excluded=12; Pruned=0; Remaining=12)
  1000   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   906   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   861   C0229664:peripheral blood [Body Substance]
           Blood
   861   C0806987:Mononuclear cells [Cell]
   830 E C2328697:Hemal cell [Cell]
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0205100:Peripheral [Spatial Concept]
   812   C1513475:Mononuclear [Clinical Attribute]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "incubated in a humidified incubator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021178:Incubator [Manufactured Object]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in 5% CO2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]

Phrase: "for 2hours to"

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "cell adhesion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007577:Cell Adhesion [Cell Function]
   861   C0001511:Adhesion [Pathologic Function]
   861   C0175633:Adhesion [Natural Phenomenon or Process]
Processing 00000000.tx.33: Nonadherent cells were removed by gentle washes. 

Phrase: "Nonadherent cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "removed by gentle washes."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0720654:Gentle [Organic Chemical,Pharmacologic Substance]
   770   C0849355:Removed [Qualitative Concept]
   737   C0441648:Wash [Activity]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]
Processing 00000000.tx.34: The adherent cells were then cultured in complete medium supplemented with GM-CSF (100ng/mL) and IL-4 (100ng/mL; both from Schering-Plough Research Institute, Kenilworth, NJ) for 7days, with further addition of cytokines on days 3and 5.

Phrase: "The adherent cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C0334154:Adherent [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "cultured in complete medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   802   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   770   C0009458:Medium [Intellectual Product]
   770   C0205197:Complete [Qualitative Concept]
   770   C0439536:Medium [Quantitative Concept]
   770   C0725685:COMPLEAT [Food]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with GM-CSF (100ng/mL)"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0079460:GM CSF [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0376563:GM CSF [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C0546866:GM [Antibiotic,Carbohydrate]
   753   C3540512:CSF [Therapeutic or Preventive Procedure]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(100ng/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ";"

Phrase: "both from Schering-Plough Research Institute,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0035172:Research Institute [Organization]
   790   C0331973:Schering-Plough [Health Care Related Organization]
   753   C0021622:institute [Organization]
   753   C0035168:research [Research Activity]
   753   C0238767:Both [Spatial Concept]
   753   C0242481:Research [Research Activity]
   753   C1272753:Institute [Idea or Concept]
   753   C1706086:Both [Qualitative Concept]

Phrase: "Kenilworth,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")"

Phrase: "for 7days,"

Phrase: "with further addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1883712:Addition [Functional Concept]
   789 E C1524062:Additional [Functional Concept]

Phrase: "of cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "on days 3and 5."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439228:days [Temporal Concept]
   793 E C0332173:/day [Temporal Concept]
   793 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.35: During the culture, the Id or an allogeneic paraprotein (both at 50g/mL) was added on days 1and 5to pulse the cells. 

Phrase: "During the culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "the Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "an allogeneic paraprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030490:Paraprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "("

Phrase: "both at 50g/mL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0238767:Both [Spatial Concept]
   770   C0439526:/mL [Quantitative Concept]
   770   C1706086:Both [Qualitative Concept]

Phrase: "was"

Phrase: "added on days 1and 5to pulse"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0439228:days [Temporal Concept]
   753   C1524062:Added [Functional Concept]
   753   C1947910:Pulse [Phenomenon or Process]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.36: After 7days of culture, cells were harvested and phenotypically characterized to ensure they met the typical phenotype of immature DCsthat is, CD3, CD4, CD14, CD19, CD83, CD1a+, CD40+, CD80+, CD86+, HLA-DR+, HLA-ABC+.15,16 Generation of idiotype-specific cytotoxic C lymphocytes CTLs were elicited from autologous PBMCs using repeated stimulation by DCs pulsed with myeloma Id. 

Phrase: "After 7days"

Phrase: "of culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1512335:Harvest [Health Care Activity]

Phrase: "and"

Phrase: "phenotypically"

Phrase: "characterized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "they"

Phrase: "met"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Meet [Idea or Concept]

Phrase: "the typical phenotype of immature DCsthat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: ","

Phrase: "CD3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3542405:CD3 [Laboratory Procedure]

Phrase: "CD4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "CD14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367477:CD14 [Gene or Genome]
  1000   C3538991:CD14 [Laboratory Procedure]

Phrase: "CD19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540683:CD19 [Laboratory Procedure]

Phrase: "CD83,"

Phrase: "CD1a+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963782:CD1a [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413207:CD1A [Gene or Genome]

Phrase: "CD40+,"

Phrase: "CD80+,"

Phrase: "CD86+,"

Phrase: "HLA-DR+,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0019764:Human leucocyte antigen DR [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   812   C0003320:Antigen [Immunologic Factor]
   812   C0023516:Leucocyte [Cell]
   812   C0031831:DR [Professional or Occupational Group]
   812   C0086418:Human [Human]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "HLA-ABC+.15,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   804   C0003320:Antigen [Immunologic Factor]
   804   C0023516:Leucocyte [Cell]
   804   C0086418:Human [Human]
   704 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "16 Generation of idiotype-specific cytotoxic C lymphocytes CTLs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0079411:Generation [Temporal Concept]
   738   C3146294:Generation [Activity]

Phrase: "were"

Phrase: "elicited from autologous PBMCs"
Meta Candidates (Total=20; Excluded=5; Pruned=0; Remaining=15)
   853   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   789   C2347293:Mononuclear Blood Cell [Cell]
   788   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   778   C0229664:peripheral blood [Body Substance]
           Blood
   778   C0806987:Mononuclear cells [Cell]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0007634:Cells [Cell]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0439859:Autologous [Qualitative Concept]
   748   C0449265:elicited [Qualitative Concept]
   748   C1513475:Mononuclear [Clinical Attribute]
   748   C3282337:Cells [Cell]
   737 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C2328697:Hemal cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "repeated stimulation by DCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "pulsed with myeloma Id."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0026764:Myeloma [Neoplastic Process]
   770   C1947910:Pulsed [Phenomenon or Process]
   770   C3538749:Myeloma [Intellectual Product]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]
Processing 00000000.tx.37: Washed PBMCs (2106/mL) were resuspended in complete medium containing recombinant IL-2 (30IU/mL; Chiron, Emeryville, CA) and IL-7 (5ng/mL; R&D Systems, Minneapolis, MN), and Id-pulsed autologous DCs (2-5 105/mL) were added to primary cultures. 

Phrase: "Washed PBMCs"
Meta Candidates (Total=24; Excluded=12; Pruned=0; Remaining=12)
   937   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   872   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   840   C0229664:peripheral blood [Body Substance]
           Blood
   840   C0806987:Mononuclear cells [Cell]
   808 E C2328697:Hemal cell [Cell]
   804   C0005767:Blood [Tissue]
   804   C0005768:blood [Body Substance]
   804   C0007634:Cells [Cell]
   804   C0205100:Peripheral [Spatial Concept]
   804   C1513475:Mononuclear [Clinical Attribute]
   804   C3282337:Cells [Cell]
   798 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   733 E C0333275:Bloody [Qualitative Concept]
   721 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   721 E C0392895:Bloods [Population Group]
   721 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   721 E C1511228:VESSEL, BLOOD [Tissue]
   704 E C1558950:VASCULAR [Finding]
   704 E C1801960:Vascular [Qualitative Concept]

Phrase: "(2106/mL)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "resuspended in complete medium containing recombinant IL-2"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0021756:IL2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0879590:IL2 [Gene or Genome]
   744   C0009458:Medium [Intellectual Product]
   744   C0020898:IL [Geographic Area]
   744   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0022271:IL [Geographic Area]
   744   C0205197:Complete [Qualitative Concept]
   744   C0332256:Containing [Functional Concept]
   744   C0439536:Medium [Quantitative Concept]
   744   C0725685:COMPLEAT [Food]
   744   C1514798:recombinant [Organism]
   744   C1705217:Medium [Substance]
   744   C2700400:Containing [Activity]
   744   C3244283:medium [Intellectual Product]

Phrase: "(30IU/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; Chiron,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1504071:Chiron [Eukaryote]

Phrase: "Emeryville,"

Phrase: "CA)"

Phrase: "and"

Phrase: "IL-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(5ng/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; R&D Systems,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Id-pulsed autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   884   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(2-5 105/mL)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "added to primary cultures."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0010453:Cultures [Idea or Concept]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1524062:Added [Functional Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]
   737 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.38: The cells were incubated in 50-mL tissue culture flasks at 37C in 5% CO2/95% air. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated in 50-mL tissue culture flasks"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   797   C0492793:FLASK, TISSUE CULTURE [Medical Device]
   778   C0040284:Tissue culture [Laboratory Procedure]
   748   C0010453:Culture [Idea or Concept]
   748   C0040300:Tissue [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439526:/mL [Quantitative Concept]
   748   C0872171:flasks [Medical Device]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1547928:Tissue [Intellectual Product]
   748   C2242979:Culture [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "in 5% CO2/95% air."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0001861:Air [Substance]
   812   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   729 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.39: Responder cells were restimulated with Id-pulsed autologous DCs every 2weeks, and the cultures were fed every 5days with fresh medium containing recombinant IL-2 and IL-7. 

Phrase: "Responder cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "restimulated with Id-pulsed autologous DCs"
Meta Candidates (Total=16; Excluded=7; Pruned=0; Remaining=9)
   814   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   778   C0011306:Dendritic Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0011305:Dendritic [Cell Component]
   748   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439640:Dendritic [Qualitative Concept]
   748   C0439859:Autologous [Qualitative Concept]
   748   C1947910:Pulsed [Phenomenon or Process]
   748   C3282337:Cells [Cell]
   745 E C0003315:Dendritic cell [Cell]
   745 E C1511762:Dendritic Cell [Cell]
   714 E C0232117:PULSE [Clinical Attribute]
   714 E C0391850:Pulse [Physiologic Function]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "every 2weeks,"

Phrase: "and"

Phrase: "the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "every 5days with fresh medium containing recombinant IL-2"

Phrase: "and"

Phrase: "IL-7."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]
Processing 00000000.tx.40: After 3to 4cycles of antigen stimulation and selection, T-cell lines were established and cells were expanded in complete medium containing rIL-2 (30IU/mL) and IL-7 (5ng/mL) for 2weeks and then subjected to functional tests. 

Phrase: "After 3to 4cycles"

Phrase: "of antigen stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "selection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036576:selection [Genetic Function]

Phrase: "T-cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   901   C0039194:T-cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "and"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "expanded in complete medium containing rIL-2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0009458:Medium [Intellectual Product]
   748   C0205197:Complete [Qualitative Concept]
   748   C0205229:expanded [Spatial Concept]
   748   C0332256:Containing [Functional Concept]
   748   C0439536:Medium [Quantitative Concept]
   748   C0725685:COMPLEAT [Food]
   748   C1335621:RIL [Gene or Genome]
   748   C1424333:RIL [Gene or Genome]
   748   C1705217:Medium [Substance]
   748   C2700400:Containing [Activity]
   748   C3244283:medium [Intellectual Product]

Phrase: "(30IU/mL)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "IL-7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(5ng/mL) for 2weeks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to functional tests."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0022885:Tests [Laboratory Procedure]
   770   C0205245:Functional [Functional Concept]
   770   C0392366:Tests [Intellectual Product]
   770   C0542341:Functional [Functional Concept]
   770   C2700217:Functional [Conceptual Entity]
   737 E C0039593:Test [Functional Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.41: Proliferation assays T cells (5104/100 L/well) were seeded into 96-well flat-bottom tissue culture plates. 

Phrase: "Proliferation assays T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0039194:T-Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(5104/100 L/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0205170:Well [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: "were"

Phrase: "seeded into 96-well flat-bottom tissue culture plates."
Meta Candidates (Total=21; Excluded=2; Pruned=0; Remaining=19)
   764   C0040284:Tissue culture [Laboratory Procedure]
   764   C0180454:culture plates [Medical Device]
   742   C0010453:Culture [Idea or Concept]
   742   C0040300:Tissue [Tissue]
   742   C0205170:Well [Qualitative Concept]
   742   C0205324:Flat [Spatial Concept]
   742   C0220814:culture [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0457933:Flat [Manufactured Object]
   742   C1139930:plates [Medical Device]
   742   C1511276:Bottom [Spatial Concept]
   742   C1547928:Tissue [Intellectual Product]
   742   C1552825:bottom [Idea or Concept]
   742   C2242979:Culture [Laboratory Procedure]
   742   C3146287:Well [Manufactured Object]
   708 E C0005971:Plate [Medical Device]
   708   C0036563:Seed [Plant]
   708   C1705192:Seed [Laboratory Procedure]
   708   C1882540:{Seed} [Quantitative Concept]
   708   C2346495:Seed [Conceptual Entity]
   708 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.42: DCs pulsed with the autologous Id, the allogeneic paraprotein from the other patient, or an isotype-matched Id protein from other patients were added to cultures in different concentrations, and cultures were incubated at 37C in 5% CO2/95% air for 4days. 

Phrase: "DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]

Phrase: "the allogeneic paraprotein from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030490:Paraprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "other patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "or"

Phrase: "an isotype-matched Id protein from other patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "added to cultures"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0010453:Cultures [Idea or Concept]
   790   C1524062:Added [Functional Concept]
   756 E C0220814:culture [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C1883712:Add [Functional Concept]
   756 E C2242979:Culture [Laboratory Procedure]

Phrase: "in different concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "incubated at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 5% CO2/95% air"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0001861:Air [Substance]
   812   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   729 E C0070924:AIRS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "for 4days."
Processing 00000000.tx.43: T-cell proliferation was measured using overnight incubation with [3H]-thymidine (0.5Ci/well; Amersham Pharmacia Biotech, Piscataway, NJ). 

Phrase: "T-cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1155046:T-Cell Proliferation [Cell Function]
   901   C0596290:Cell Proliferation [Cell Function]
   827   C0334094:Proliferation [Pathologic Function]
   827   C1514485:Proliferation [Functional Concept]
   734   C0039194:T-cell [Cell]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "overnight incubation with"

Phrase: "[3H]-thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]

Phrase: "(0.5Ci/well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]

Phrase: "; Amersham Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Piscataway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551491:Piscataway [Population Group]

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.44: Results from triplicate cultures are given as the arithmetic means. 

Phrase: "Results from triplicate cultures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "are"

Phrase: "given as the arithmetic means."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0871653:arithmetic [Intellectual Product]
   760   C1442162:GIVEN [Conceptual Entity]
   760   C1550718:given [Idea or Concept]
   760   C1704970:Means [Conceptual Entity]
   760   C3244317:given [Intellectual Product]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C1947971:Give [Functional Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.45: Cytotoxicity assays Target cells included autologous DCs pulsed with the autologous Id, the allogeneic paraprotein from the other patient and an isotype-matched Id protein, thawed autologous or allogeneic primary myeloma cells from the other patient, and Ficoll-Hypaque centrifuged to get rid of dead cells. 

Phrase: "Cytotoxicity assays Target cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   861   C0221284:Target cells [Cell]
   861   C3272919:Target Cells [Laboratory Procedure]
   850   C0022686:Cytotoxic cell [Cell]
   812   C0007634:Cells [Cell]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]

Phrase: "the allogeneic paraprotein from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030490:Paraprotein [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "an isotype-matched Id protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "thawed autologous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439859:Autologous [Qualitative Concept]

Phrase: "or"

Phrase: "allogeneic primary myeloma cells from the"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0333843:cells myeloma [Cell]
   783   C3485979:Cells, Allogeneic [Cell]
   753   C0007634:Cells [Cell]
   753   C0026764:Myeloma [Neoplastic Process]
   753   C3282337:Cells [Cell]
   753   C3538749:Myeloma [Intellectual Product]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "other patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "and"

Phrase: "Ficoll-Hypaque"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0813724:Hypaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "centrifuged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0179834:centrifuge [Medical Device]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "get"

Phrase: "rid of dead cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0073361:RID [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.46: Cells were labeled with sodium chromium Cr 51chromate for 1hour, and 1104 target cells/well were mixed with various numbers of effector cells in a standard 4-hour cytotoxicity assay using 96-well round-bottom plates. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "labeled with sodium chromium Cr 51chromate"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   783   C0008574:Cr - Chromium [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
           Chromium
   753   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   753   C0201975:Cr [Laboratory Procedure]
   753   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1445745:Chromium [Pharmacologic Substance]
   753   C1708632:Labeled [Qualitative Concept]
   753   C2348261:Chromium [Element, Ion, or Isotope]
   753   C3539604:CR [Gene or Genome]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "for 1hour,"

Phrase: "and"

Phrase: "1104 target cells/well"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   861   C0221284:Target cells [Cell]
   861   C2347578:Cells/well [Quantitative Concept]
   861   C3272919:Target Cells [Laboratory Procedure]
   812   C0007634:Cells [Cell]
   812   C0205170:Well [Qualitative Concept]
   812   C1521840:Target [Functional Concept]
   812   C2986546:TARGET [Diagnostic Procedure]
   812   C3146287:Well [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "mixed with various numbers of effector cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0007634:Cells [Cell]
   748   C0205430:Mixed [Functional Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C0449788:Number [Quantitative Concept]
   748   C3160715:Mixed [Finding]
   748   C3282337:Cells [Cell]
   745   C0312740:Effector Cell [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1421951:MIX [Gene or Genome]
   714 E C1704653:Cell [Medical Device]
   714 E C1720722:Mix [Qualitative Concept]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "in a standard 4-hour cytotoxicity assay"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   840   C0201622:Cytotoxicity assay [Laboratory Procedure]
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   804   C1510438:Assay [Laboratory Procedure]
   733 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   733 E C1511636:cytotoxic [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "96-well round-bottom plates."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   804   C1139930:plates [Medical Device]
   771 E C0005971:Plate [Medical Device]
   771 E C3537155:Plate [Manufactured Object]
Processing 00000000.tx.47: All assays were performed at least in triplicate. 

Phrase: "All assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at least"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.48: Results are shown as mean percentage 51Cr release calculated as follows: [(sample countsspontaneous counts)/(maximum countsspontaneous counts)] 100. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "shown as mean percentage 51Cr release"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439165:Percentage [Quantitative Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0444504:Mean [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]
   719   C1547282:Show [Intellectual Product]

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "as"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "(sample countsspontaneous counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "/"

Phrase: "(maximum countsspontaneous counts"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0439157:counts [Quantitative Concept]
   793 E C0750480:Count [Activity]
   793 E C1705566:Count [Quantitative Concept]

Phrase: ")"

Phrase: "] 100."
Processing 00000000.tx.49: Spontaneous release was less than 25% of the maximum [51Cr] uptake. 

Phrase: "Spontaneous release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "less than 25% of the maximum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0439092:Less Than [Intellectual Product]
           less
   753   C0547044:Less [Qualitative Concept]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1552615:maximum [Quantitative Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "[51Cr"

Phrase: "] uptake."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]
Processing 00000000.tx.50: To determine whether the cytolytic activity was restricted by major histocompatibility complex (MHC) class I or II molecules, antibodies against human leukocyte antigen (HLA)-ABC (W6/32; Serotec, Oxford, United Kingdom) or HLA-DR (B8.12.2; Immunotech, Marseilles, France) and an isotopic control mouse IgG (Immunotech) at 10g/mL were added to the cultures at the initiation of the assay. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the cytolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "restricted by major histocompatibility complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0024518:Major Histocompatibility Complex [Gene or Genome]
   862   C1753349:Major histocompatibility complex [Cell Component]
   760   C0019627:Histocompatibility [Qualitative Concept]
   760   C0205164:Major [Qualitative Concept]
   760   C0439855:Complex [Qualitative Concept]
   760   C0443288:Restricted [Functional Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(MHC) class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "or"

Phrase: "II molecules,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "antibodies against human leukocyte antigen (HLA)-ABC (W6/32"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0368675:antibodies antigen [Immunologic Factor]
   744   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   711 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "; Serotec,"

Phrase: "Oxford,"

Phrase: "United Kingdom"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0041700:United Kingdom [Geographic Area]
   861   C1708611:Kingdom [Classification]
   827   C0166872:unite [Biomedical or Dental Material]

Phrase: ")"

Phrase: "or"

Phrase: "HLA-DR"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0019764:Human leucocyte antigen DR [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   812   C0003320:Antigen [Immunologic Factor]
   812   C0023516:Leucocyte [Cell]
   812   C0031831:DR [Professional or Occupational Group]
   812   C0086418:Human [Human]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "(B8.12.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0507118:B8 [Body Part, Organ, or Organ Component]
   827   C1417622:B8 [Gene or Genome]

Phrase: "; Immunotech,"

Phrase: "Marseilles,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "an isotopic control mouse IgG (Immunotech"

Phrase: ")"

Phrase: "at 10g/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "added to the cultures"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0010453:Cultures [Idea or Concept]
   770   C1524062:Added [Functional Concept]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C1883712:Add [Functional Concept]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "at the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of the assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.51: Inhibition of perforin- and Fas-mediated pathways of cytolysis Concanamycin A (CMA; Sigma), an inhibitor of vacuolar type H+-adenosine triphosphate (ATPase), or Brefeldin A (Sigma) was used as a selective inhibitor of perforin-mediated and Fas-mediated cytotoxicity,17 respectively. 

Phrase: "Inhibition of perforin-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "and"

Phrase: "Fas-mediated pathways of cytolysis Concanamycin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1704259:Pathways [Molecular Function]
   748   C1705987:Pathways [Conceptual Entity]

Phrase: "(CMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347595:CMA [Occupation or Discipline]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "an inhibitor of vacuolar type H+-adenosine triphosphate (ATPase),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "or"

Phrase: "Brefeldin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "used as a selective inhibitor of perforin-mediated"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   750   C1524063:Use of [Functional Concept]
   744   C0070410:perforin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C1273517:used [Finding]
   744   C1418887:Perforin [Gene or Genome]
   744   C1999216:Inhibitor [Qualitative Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "Fas-mediated cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "17 respectively."
Processing 00000000.tx.52: Effector cells were pretreated with 100nmol/L CMA or 10mol/L Brefeldin A for 2hours and assayed for cytotoxicity in the presence of the drugs. 

Phrase: "Effector cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0312740:Effector Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "pretreated with 100nmol/L CMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2347595:CMA [Occupation or Discipline]

Phrase: "or"

Phrase: "10mol/L Brefeldin A for 2hours"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   753   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "assayed for cytotoxicity"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   841   C0201622:Cytotoxicity assay [Laboratory Procedure]
   790   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   756   C0005507:Assay [Laboratory Procedure]
   756   C0243073:assay [Qualitative Concept]
   756   C1510438:Assay [Laboratory Procedure]
   718 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   718 E C1511636:cytotoxic [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the drugs."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0013227:Drugs [Pharmacologic Substance]
   966 E C1254351:Drug [Pharmacologic Substance]
   928 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   928 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   900 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.53: Enzyme-linked immunospot assay The detailed methods of the enzyme-linked immunospot (ELISPOT) assay for the enumeration of antigen-specific, cytokine-secreting cells have been described previously.18,19 Briefly, plates (Millititer-HAM; Millipore, Bedford, MA) were coated with mouse monoclonal anti-human interferon (IFN-) (1g/mL), IL-4 (2.5g/mL), or tumor necrosis factor (TNF)- (2.5.g/mL) (R&D Systems). 

Phrase: "Enzyme-linked immunospot assay"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0920508:Enzyme-Linked Immunospot Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "The detailed methods of the enzyme-linked immunospot (ELISPOT) assay"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   745   C0450074:Enzyme method [Intellectual Product]
   742   C0025663:Methods [Intellectual Product]
   742   C0025664:methods [Intellectual Product]
   742   C0449851:Methods [Functional Concept]
   708 E C0871511:METHOD [Intellectual Product]

Phrase: "for the enumeration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707927:Enumeration [Qualitative Concept]

Phrase: "of antigen-specific, cytokine-secreting cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously.18,"

Phrase: "19 Briefly,"

Phrase: "plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "(Millititer-HAM"

Phrase: "; Millipore,"

Phrase: "Bedford,"

Phrase: "MA)"

Phrase: "were"

Phrase: "coated with mouse monoclonal anti-human interferon"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0086418:Human [Human]
   748   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]
   748   C1522408:Coated [Qualitative Concept]
   714 E C0453946:Coat [Manufactured Object]
   714 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(1g/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(2.5g/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "tumor necrosis factor (TNF)-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(2.5.g/mL) (R&D Systems"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   829   C0439446:mL/d [Quantitative Concept]
   762   C0449913:System [Functional Concept]
   762   C1553451:System [Manufactured Object]
   762   C1704459:System [Medical Device]
   712 E C0205373:Systemic [Functional Concept]

Phrase: ")."
Processing 00000000.tx.54: Cultured T cells (104 cells/well) were added and incubated with Id-pulsed DCs for 36hours at 37C. 

Phrase: "Cultured T cells"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   913   C0007600:cultured cells [Cell]
   913   C0007635:Cultured Cells [Cell]
   913   C3282338:Cells, Cultured [Cell]
   901   C0039194:T-Cells [Cell]
   880 E C0007585:culture cell [Laboratory Procedure]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793   C0010453:Culture [Idea or Concept]
   793   C0220814:culture [Functional Concept]
   793   C0430400:Culture [Laboratory Procedure]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   793   C2242979:Culture [Laboratory Procedure]

Phrase: "(104 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C2347578:Cells/well [Quantitative Concept]
   827   C0007634:Cells [Cell]
   827   C0205170:Well [Qualitative Concept]
   827   C3146287:Well [Manufactured Object]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated with Id-pulsed DCs"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   790   C0011306:Dendritic Cells [Cell]
   756 E C0003315:Dendritic cell [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1947910:Pulsed [Phenomenon or Process]
   753   C3282337:Cells [Cell]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C0391850:Pulse [Physiologic Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "for 36hours"

Phrase: "at 37C."
Processing 00000000.tx.55: Cells incubated without target cells or with phytohemagglutinin (10g/mL; Sigma) were used as controls. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "incubated without target cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0221284:Target cells [Cell]
   833   C3272919:Target Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "or with phytohemagglutinin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0031858:Phytohaemagglutinin [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]

Phrase: "(10g/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "used as controls."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756   C0243148:control [Qualitative Concept]
   756 E C0457083:Use [Functional Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756 E C1947944:Use [Intellectual Product]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.56: After incubation, cells were detached from the plates by washing, and polyclonal anti-human IFN- (250ng/mL), IL-4 (1g/mL) (R&D System), or TNF- (4g/mL; Serotec) was added and incubated for 2hours. 

Phrase: "After incubation,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "detached from the plates"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0687118:Detached [Functional Concept]
   770   C1139930:plates [Medical Device]
   770   C1561504:detached [Idea or Concept]
   737 E C0005971:Plate [Medical Device]
   737 E C3537155:Plate [Manufactured Object]

Phrase: "by washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "and"

Phrase: "polyclonal anti-human IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(250ng/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(1g/mL) (R&D System"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "(4g/mL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; Serotec"

Phrase: ")"

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "incubated for 2hours."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]
Processing 00000000.tx.57: The spots were developed by sequential incubation with biotinylated antigoat (1/500; IFN- and IL-4) or antirabbit (1/100; TNF-) antibodies (Vector Labs, Burlingame, CA), followed by peroxidase staining, using the substrate 3-amino-9-ethyl-carbazol (Sigma). 

Phrase: "The spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "were"

Phrase: "developed by sequential incubation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1548958:Sequential [Idea or Concept]
   770   C1705294:Sequential [Qualitative Concept]

Phrase: "with biotinylated antigoat"

Phrase: "(1/500"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: "or"

Phrase: "antirabbit"

Phrase: "(1/100"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "; TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: ")"

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Vector Labs,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0587081:Labs [Finding]
   827 E C0022877:Lab [Manufactured Object,Organization]
   789 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "Burlingame,"

Phrase: "CA),"

Phrase: "followed by peroxidase staining,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332283:Followed by [Temporal Concept]
           followed
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the substrate 3-amino-9-ethyl-carbazol"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.58: Spots corresponding to the cytokine-secreting cells were enumerated under a dissection microscope (Stemi SV6; Zeiss, Jena, Germany). 

Phrase: "Spots"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015230:spots [Disease or Syndrome]
  1000   C0329155:Spot [Fish]
  1000   C0848332:Spots [Sign or Symptom]
  1000   C1427618:SPOT [Gene or Genome]
  1000   C1705203:Spot [Conceptual Entity]

Phrase: "corresponding to the cytokine-secreting cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0007634:Cells [Cell]
   753   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C1327616:Secreting [Cell Function]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "enumerated under a dissection microscope"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012737:Dissection [Therapeutic or Preventive Procedure]
   760   C0181839:Microscope [Medical Device]
   760   C1706379:Microscope [Medical Device]
   760   C1707927:Enumerated [Qualitative Concept]

Phrase: "(Stemi SV6"

Phrase: "; Zeiss,"

Phrase: "Jena,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.59: All samples were run in duplicate. 

Phrase: "All samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "run in duplicate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205173:Duplicate [Functional Concept]
   827   C3539942:Duplicate [Intellectual Product]
   734   C3274438:RUN-IN [Temporal Concept]
Processing 00000000.tx.60: Data are expressed as the mean number of cytokine-secreting cells/104 T cells. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the mean number"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0237753:*Number [Quantitative Concept]
   760   C0444504:Mean [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]

Phrase: "of cytokine-secreting cells/104 T cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039194:T-Cells [Cell]
Processing 00000000.tx.61: Immunophenotyping Immunophenotyping was carried out on all cultured cells using a fluorescence-activated cell scan (Facscan; Becton Dickinson, San Jose, CA) and analyzed by Lysis II program. 

Phrase: "Immunophenotyping Immunophenotyping"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on all cultured cells"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   806   C0007600:cultured cells [Cell]
   806   C0007635:Cultured Cells [Cell]
   806   C3282338:Cells, Cultured [Cell]
   781 E C0007585:cells culture [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726   C0010453:Culture [Idea or Concept]
   726   C0220814:culture [Functional Concept]
   726   C0430400:Culture [Laboratory Procedure]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726   C2242979:Culture [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a fluorescence-activated cell scan"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034606:Scan [Diagnostic Procedure]
   812   C0441633:Scan [Diagnostic Procedure]
   812   C2826292:SCAN [Finding]

Phrase: "(Facscan"

Phrase: "; Becton Dickinson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331782:Becton Dickinson [Health Care Related Organization]

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "analyzed by Lysis II program."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0024348:Lysis [Pathologic Function]
   760   C0936012:Analyzed [Research Activity]
   760   C1536403:lysis [Cell Function]
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]
Processing 00000000.tx.62: Briefly, cells were first washed twice in washing buffer (phosphate-buffered saline+2% bovine serum albumin and 0.5% sodium azide). 

Phrase: "Briefly,"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "twice in washing buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0441648:Washing [Activity]
   770   C1720725:Twice [Intellectual Product]
   770   C1948050:Twice [Quantitative Concept]

Phrase: "(phosphate-buffered saline+2% bovine serum albumin"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   877   C0036820:phosphate serum [Laboratory Procedure]
   845   C0036774:Serum Albumin, Bovine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0036773:Serum Albumin [Amino Acid, Peptide, or Protein]
   818   C0728877:serum albumin [Laboratory or Test Result]
   795   C0001924:Albumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   795   C0007452:Bovine [Mammal]
   795   C0229671:Serum [Body Substance]
   795   C1140701:bovine [Mammal]
   795   C1546774:Serum [Intellectual Product]
   795   C1550100:Serum [Body Substance]

Phrase: "and"

Phrase: "0.5% sodium azide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   812   C0004492:azide [Chemical Viewed Structurally]

Phrase: ")."
Processing 00000000.tx.63: Phycoerythrin- or fluorescein isothiocyanate-conjugated monoclonal antibodies (Immunotech) at the manufacturer's recommended concentrations were added to each cell pellet, and the cells were incubated on ice for 30minutes before they were washed 3times and resuspended in phosphate-buffered saline ready for analysis. 

Phrase: "Phycoerythrin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031789:Phycoerythrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "fluorescein isothiocyanate-conjugated monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0746619:monoclonal [Finding]
   771 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Immunotech"

Phrase: ")"

Phrase: "at the manufacturer's recommended concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "added to each cell pellet,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0007634:Cell [Cell]
   760   C0441436:Pellet [Manufactured Object]
   760   C0993610:Pellet [Biomedical or Dental Material]
   760   C1269647:Cell [Cell]
   760   C1524062:Added [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C1998480:Pellet [Quantitative Concept]
   726 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 30minutes"

Phrase: "before"

Phrase: "they"

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "3times"

Phrase: "and"

Phrase: "resuspended in phosphate-buffered saline"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "ready for analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C1318963:Readiness [Finding]
Processing 00000000.tx.64: Controls consisted of cells stained with irrelevant mouse IgG antibodies.  

Phrase: "Controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "consisted of cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756   C0332529:CONSIST [Qualitative Concept]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "stained with irrelevant mouse IgG antibodies."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   773   C2754943:IgG antibody [Cell Component]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0025914:Mouse [Mammal]
   753   C0025929:mouse [Mammal]
   753   C0026809:Mouse [Mammal]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.65: Results Top Abstract Introduction Materials and methods Results Discussion References Idiotype-pulsed dendritic cells induce idiotype-specific T-cell responses in vitro To enhance the immunogenicity of Id, we used DCs as APCs. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Idiotype-pulsed dendritic cells"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "idiotype-specific T-cell responses in vitro To"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   793   C0871261:responses [Organism Attribute]
   760 E C1704632:Response [Finding]
   760 E C1706817:Response [Intellectual Product]
   760 E C2911692:Response [Mental Process]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the immunogenicity of Id,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DCs as APCs."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   846   C0003315:Antigen-presenting dendritic cell [Cell]
       E   Dendritic cell
   790   C0011306:Dendritic Cells [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.66: DCs were successfully generated from adherent cells of PBMCs after 7days of culture and confirmed by immunophenotyping showing that the cells were CD3, CD4, CD14, CD19, CD83, CD1a+, CD40+, CD80+, CD86+, HLA-DR+, and HLA-ABC+ (Figure 1). 

Phrase: "DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "successfully"

Phrase: "generated from adherent cells of PBMCs"
Meta Candidates (Total=21; Excluded=5; Pruned=0; Remaining=16)
   818   C1321301:Peripheral Blood Mononuclear Cells [Cell]
           Peripheral blood mononuclear cell (cell)
   770   C2347293:Mononuclear Blood Cell [Cell]
   767   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   764   C0229664:peripheral blood [Body Substance]
           Blood
   764   C0806987:Mononuclear cells [Cell]
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0007634:Cells [Cell]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0334154:Adherent [Functional Concept]
   742   C1513475:Mononuclear [Clinical Attribute]
   742   C3146294:Generated [Activity]
   742   C3282337:Cells [Cell]
   723 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   717 E C2328697:Hemal cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "after 7days"

Phrase: "of culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "confirmed by immunophenotyping"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0079611:Immunophenotyping [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "CD3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3542405:CD3 [Laboratory Procedure]

Phrase: "CD4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "CD14,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1367477:CD14 [Gene or Genome]
  1000   C3538991:CD14 [Laboratory Procedure]

Phrase: "CD19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540683:CD19 [Laboratory Procedure]

Phrase: "CD83,"

Phrase: "CD1a+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0963782:CD1a [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1413207:CD1A [Gene or Genome]

Phrase: "CD40+,"

Phrase: "CD80+,"

Phrase: "CD86+,"

Phrase: "HLA-DR+,"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0019764:Human leucocyte antigen DR [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   812   C0003320:Antigen [Immunologic Factor]
   812   C0023516:Leucocyte [Cell]
   812   C0031831:DR [Professional or Occupational Group]
   812   C0086418:Human [Human]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "and"

Phrase: "HLA-ABC+ (Figure 1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   885   C0598074:leukocyte antigen 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C0054964:Leucocyte 1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   876   C0242821:Human Figure [Human]
   861   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   799   C0003320:Antigen [Immunologic Factor]
   799   C0023516:Leucocyte [Cell]
   799   C0086418:Human [Human]

Phrase: ")."
Processing 00000000.tx.67: View larger version (49K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.68: Flow cytometry analysis. 

Phrase: "Flow cytometry analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0016263:Flow Cytometry [Laboratory Procedure]
Processing 00000000.tx.69: Histograms with closed areas depict DCs expressing different surface markers. 

Phrase: "Histograms with closed areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348974:Histogram [Manufactured Object]

Phrase: "depict"

Phrase: "DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "different surface markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.70: Histograms with open areas depict staining with isotype-matched control antibody. 

Phrase: "Histograms with open areas"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2348974:Histogram [Manufactured Object]

Phrase: "depict"

Phrase: "staining with isotype-matched control antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]
Processing 00000000.tx.71: Gate was set on the big cell population. 

Phrase: "Gate"

Phrase: "was"

Phrase: "set on the big cell population."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0007634:Cell [Cell]
   753   C0032659:Population [Quantitative Concept]
   753   C0036849:Set [Mental Process]
   753   C0549177:Big [Quantitative Concept]
   753   C1257890:Population [Population Group]
   753   C1269647:Cell [Cell]
   753   C1442518:Set [Functional Concept]
   753   C1704653:Cell [Medical Device]
   753   C1705195:Set [Conceptual Entity]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.72: These results are representative of at least 6independent experiments. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least 6independent experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.73: We initially examined the immune response to myeloma Id in primary cultures. 

Phrase: "We initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the immune response to myeloma Id"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0301872:Immune response [Organ or Tissue Function]
   753   C0439662:Immune [Functional Concept]
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "in primary cultures."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0010453:Cultures [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.74: No significant proliferative response was observed in any of the repeated experiments using either freshly recovered PBMC or rIL-2 (50IU/mL) pretreated PBMCs (data not shown). 

Phrase: "No significant proliferative response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "observed in any of the repeated experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0205341:Repeated [Functional Concept]
   748   C0681814:Experiments [Research Activity]
   748   C1441672:Observed [Functional Concept]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either freshly recovered PBMC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1321301:PBMC [Cell]

Phrase: "or"

Phrase: "rIL-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1335621:RIL [Gene or Genome]
   861   C1424333:RIL [Gene or Genome]

Phrase: "(50IU/mL)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "pretreated"

Phrase: "PBMCs"
Meta Candidates (Total=24; Excluded=12; Pruned=0; Remaining=12)
  1000   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   906   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   861   C0229664:peripheral blood [Body Substance]
           Blood
   861   C0806987:Mononuclear cells [Cell]
   830 E C2328697:Hemal cell [Cell]
   819 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0007634:Cells [Cell]
   812   C0205100:Peripheral [Spatial Concept]
   812   C1513475:Mononuclear [Clinical Attribute]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.75: However, after repeated rounds of T-cell stimulation with Id-pulsed DCs, Id-specific T-cell lines were generated and propagated from PBMCs from both myeloma patients. 

Phrase: "However,"

Phrase: "after"

Phrase: "repeated rounds of T-cell stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0487470:round cell [Cell]
   719   C0332490:Round [Spatial Concept]

Phrase: "with Id-pulsed DCs,"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "Id-specific T-cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0007600:Cell lines [Cell]
   840   C0039194:T-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "propagated from PBMCs"
Meta Candidates (Total=18; Excluded=5; Pruned=0; Remaining=13)
   882   C1321301:Peripheral Blood Mononuclear Cells [Cell]
   804   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   803   C2347293:Mononuclear Blood Cell [Cell]
   790   C0229664:peripheral blood [Body Substance]
           Blood
   790   C0806987:Mononuclear cells [Cell]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0007634:Cells [Cell]
   753   C0205100:Peripheral [Spatial Concept]
   753   C1513475:Mononuclear [Clinical Attribute]
   753   C3282337:Cells [Cell]
   748 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   739 E C2328697:Hemal cell [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "from both myeloma patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.76: Id-specific proliferative responses were observed when T cells were rechallenged with the autologous Id-pulsed DCs (Figure 2A-B). 

Phrase: "Id-specific proliferative responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "rechallenged with the autologous Id-pulsed DCs"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   793   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   770   C0011306:Dendritic Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0011305:Dendritic [Cell Component]
   744   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439640:Dendritic [Qualitative Concept]
   744   C0439859:Autologous [Qualitative Concept]
   744   C1947910:Pulsed [Phenomenon or Process]
   744   C3282337:Cells [Cell]
   737 E C0003315:Dendritic cell [Cell]
   737 E C1511762:Dendritic Cell [Cell]
   711 E C0232117:PULSE [Clinical Attribute]
   711 E C0391850:Pulse [Physiologic Function]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711   C2347900:Rechallenge [Therapeutic or Preventive Procedure]

Phrase: "(Figure 2A-B"

Phrase: ")."
Processing 00000000.tx.77: No proliferative response was noted when T cells were restimulated with autologous DCs pulsed with the allogeneic or isotype-matched Id proteins. 

Phrase: "No proliferative response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "when"

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "restimulated with autologous DCs"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   862   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   806   C0011306:Dendritic Cells [Cell]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C0439859:Autologous [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the allogeneic"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1515895:Allogeneic [Qualitative Concept]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "or"

Phrase: "isotype-matched Id proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.78: These results suggest that autologous T cells could recognize immune epitope(s) within the myeloma Id proteins, which had been taken up, processed, and presented by DCs. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that autologous T cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C1711172:Autologous T-cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "could"

Phrase: "recognize"

Phrase: "immune epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "("

Phrase: "s) within the myeloma Id proteins,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   783   C0027015:Myeloma Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   767   C1418948:PROTEIN S [Gene or Genome]
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0026764:Myeloma [Neoplastic Process]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C2603362:S' [Clinical Attribute]
   753   C3538749:Myeloma [Intellectual Product]

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "taken up,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "and"

Phrase: "presented by DCs."
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C0449450:Presented [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0150312:Present [Quantitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.79: View larger version (17K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.80: Proliferative responses. 

Phrase: "Proliferative responses."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]
Processing 00000000.tx.81: Proliferative response (cpm) of CTL lines generated from patients 1(A) and 2(B), in response to DCs pulsed with the autologous Id (), the allogeneic Id from the other patient (), or an isotype-matched () Id protein. 

Phrase: "Proliferative response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "(cpm) of CTL lines"

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "the allogeneic Id from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "an isotype-matched"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0150103:matched [Research Activity]
   861   C1708943:Matched [Qualitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "Id protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.82: (C) Inhibition by antibodies against MHC class I and class II or an isotypic control IgG on Id-induced proliferation of CTLs from patients 1() and 2(). 

Phrase: "(C) Inhibition by antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "against MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "and"

Phrase: "class II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441886:Class II [Intellectual Product]
  1000   C2698968:Class II [Finding]

Phrase: "or"

Phrase: "an isotypic control IgG on Id-induced proliferation of CTLs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   751   C0020854:IgG(T) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751   C1115671:Lymphocytes.IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "from patients 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.83: These results are representative of 3independent experiments. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of 3independent experiments."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882932:Representative [Activity]
Processing 00000000.tx.84: The T-cell proliferative responses observed in both patients were blocked partially by monomorphic monoclonal antibody to HLA class I and II molecules (Figure 2C). 

Phrase: "The T-cell proliferative responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0871261:responses [Organism Attribute]
   779 E C1704632:Response [Finding]
   779 E C1706817:Response [Intellectual Product]
   779 E C2911692:Response [Mental Process]

Phrase: "observed in both patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "partially by monomorphic monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "to HLA class I"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0008897:Human leukocyte antigen class I [Immunologic Factor,Organic Chemical]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0021966:I- [Inorganic Chemical]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   717   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "II molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "(Figure 2C"

Phrase: ")."
Processing 00000000.tx.85: In patient 1,the blocking was observed predominantly with the HLA class I antibody, whereas in patient 2,the blocking was observed mainly with the HLA class II antibody. 

Phrase: "In patient 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "the blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "predominantly with the HLA class I antibody,"
Meta Candidates (Total=22; Excluded=0; Pruned=0; Remaining=22)
   849   C0008897:Human leukocyte antigen class I [Immunologic Factor,Organic Chemical]
   790   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   764   C0221138:I not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           I NOS
   764   C0370188:i Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   764   C0441885:Class I [Classification]
   764   C2698967:Class I [Finding]
   762   C0021017:Antibody class [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0212009:I-antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0368675:antibody antigen [Immunologic Factor]
   762   C0443800:i antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0003320:Antigen [Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0021966:I- [Inorganic Chemical]
   742   C0023516:Leucocyte [Cell]
   742   C0086418:Human [Human]
   742   C0456387:Class [Intellectual Product]
   742   C1705943:Class [Classification]

Phrase: "whereas in patient 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030705:*^patient [Patient or Disabled Group]

Phrase: "the blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "mainly with the HLA class II antibody."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   849   C0312653:Human leukocyte antigen class II [Immunologic Factor]
   790   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Class II Antigen
   790   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   764   C0441886:Class II [Intellectual Product]
   764   C2698968:Class II [Finding]
   762   C0021017:Antibody class [Amino Acid, Peptide, or Protein,Immunologic Factor]
   762   C0368675:antibody antigen [Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0003320:Antigen [Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0023516:Leucocyte [Cell]
   742   C0086418:Human [Human]
   742   C0456387:Class [Intellectual Product]
   742   C1705943:Class [Classification]
Processing 00000000.tx.86: A combination of these 2antibodies produced a synergistic inhibition of the proliferative response (data not shown). 

Phrase: "A combination of these 2antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205195:Combination [Qualitative Concept]
   760   C1947911:Combination [Physical Object]

Phrase: "produced"

Phrase: "a synergistic inhibition of the proliferative response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1510574:Response Inhibition [Mental Process]
   774   C3463820:Response Inhibition [Activity]
           Inhibition
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: These results indicate that the recognition of Id T-cell epitopes was mediated through MHC class I and II molecules. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the recognition of Id T-cell epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "was"

Phrase: "mediated through MHC class I"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C0024518:Major Histocompatibility Complex [Gene or Genome]
   814   C1753349:Major histocompatibility complex [Cell Component]
   778   C0441885:Class I [Classification]
   778   C2698967:Class I [Finding]
   774   C2245017:Complex I [Cell Component]
   748   C0019627:Histocompatibility [Qualitative Concept]
   748   C0021966:I- [Inorganic Chemical]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205164:Major [Qualitative Concept]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439855:Complex [Qualitative Concept]
   748   C0456387:Class [Intellectual Product]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705943:Class [Classification]

Phrase: "and"

Phrase: "II molecules."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.88: This was supported by flow cytometry analysis showing that the Id-specific T-cell lines consisted of approximately 45% CD8+ and 55% CD4+ T cells. 

Phrase: "This"

Phrase: "was"

Phrase: "supported by flow cytometry analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1524024:analysis [Functional Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Id-specific T-cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   840   C0007600:Cell lines [Cell]
   840   C0039194:T-cell [Cell]
   804   C0007634:Cell [Cell]
   804   C0205132:lines [Spatial Concept]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
   771 E C1550648:Line [Substance]
   771 E C1552960:Line [Quantitative Concept]

Phrase: "consisted of approximately 45% CD8+"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332232:Approximately [Qualitative Concept]
   760   C3538720:CD8 [Laboratory Procedure]
   760   C3540595:CD8 [Gene or Genome]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "and"

Phrase: "55% CD4+ T cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   875   C0039215:cd4 cells [Cell]
   861   C0039194:T-Cells [Cell]
   858 E C3251824:CD4+ cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.89: Cytolytic activity of the T cells against idiotype-pulsed dendritic cells To test whether an Id-specific CTL response could be effectively induced with Id-pulsed DCs, we next assessed the cytotoxic activity of Id-specific T cells in vitro. 

Phrase: "Cytolytic activity of the T cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "against idiotype-pulsed dendritic cells To"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "an Id-specific CTL response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0871261:Response [Organism Attribute]
   799   C1704632:Response [Finding]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "could"

Phrase: "be"

Phrase: "effectively"

Phrase: "induced with Id-pulsed DCs,"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   790   C0011306:Dendritic Cells [Cell]
   756 E C0003315:Dendritic cell [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205263:Induced [Functional Concept]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C1947910:Pulsed [Phenomenon or Process]
   753   C3282337:Cells [Cell]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C0391850:Pulse [Physiologic Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "we next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the cytotoxic activity of Id-specific T cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C0039195:Cytotoxic T Cells [Cell]
   750   C0022686:Cytotoxic cell [Cell]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   744   C1511636:cytotoxic [Functional Concept]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.90: As target cells, autologous DCs and DCs pulsed with autologous, allogeneic, or isotype-matched Id proteins were used. 

Phrase: "As target cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with autologous, allogeneic,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0439859:Autologous [Qualitative Concept]
   770   C1515895:Allogeneic [Qualitative Concept]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "or"

Phrase: "isotype-matched Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.91: As shown in Figure 3A, Id-specific CTL lines lysed the autologous DCs pulsed with the autologous Id. 

Phrase: "As"

Phrase: "shown in Figure 3A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]

Phrase: "Id-specific CTL lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0039195:Cytotoxic T lymphocyte [Cell]
   827   C0039194:T-Lymphocyte [Cell]
   799   C0024264:Lymphocyte [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   799   C1511636:cytotoxic [Functional Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "the autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]
Processing 00000000.tx.92: No significant killing was observed in autologous DCs without antigen pulsing or in autologous DCs pulsed with the allogeneic or isotype-matched Id proteins (Figure 3B). 

Phrase: "No significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "was"

Phrase: "observed in autologous DCs"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   862   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   806   C0011306:Dendritic Cells [Cell]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "without antigen pulsing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]

Phrase: "or in autologous DCs"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   862   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   806   C0011306:Dendritic Cells [Cell]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C0439859:Autologous [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the allogeneic"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1515895:Allogeneic [Qualitative Concept]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "or"

Phrase: "isotype-matched Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Figure 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.93: The results indicate that the T cells were able to mediate Id-specific cytotoxicity. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "Id-specific cytotoxicity."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.94: View larger version (18K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.95: Cytotoxicity of CTLs against DCs. 

Phrase: "Cytotoxicity of CTLs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   808   C0039195:Cytotoxic T-Lymphocytes [Cell]
   781   C0301896:Lymphocyte Cytotoxicity [Cell Function]
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "against DCs."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.96: (A) Cytotoxicity of CTL lines generated from patients 1() and 2() against DCs pulsed with the autologous Id at different effector-target (E:T) ratios. 

Phrase: "(A) Cytotoxicity of CTL lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0301896:Lymphocyte Cytotoxicity [Cell Function]
   769   C0039195:Cytotoxic T lymphocyte [Cell]
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")"

Phrase: "against DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]

Phrase: "at different effector-target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]

Phrase: "(E:T) ratios."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0456603:Ratios [Quantitative Concept]
   827   C1610540:*Ratios [Quantitative Concept]
   793 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.97: (B) Comparison of the cytotoxicity of CTLs from patients 1() and 2() against DCs pulsed with the autologous Id (Auto-Id-DCs), the allogeneic Id protein from the other patient (Allo-Id-DCs), an isotype-matched Id protein (Iso-Id-DCs), or unpulsed DCs (DCs only). 

Phrase: "(B) Comparison of the cytotoxicity of CTLs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "from patients 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")"

Phrase: "against DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the autologous Id (Auto-Id-DCs),"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]

Phrase: "the allogeneic Id protein from the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(Allo-Id-DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "an isotype-matched Id protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Iso-Id-DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "unpulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(DCs only"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.98: The E:T ratio was 20:1. 

Phrase: "The E:T ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "20"

Phrase: ":"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.99: (C) Inhibition by antibodies against MHC class I and class II or an isotypic control IgG on the cytotoxicity of CTLs from patients 1() and 2(). 

Phrase: "(C) Inhibition by antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "against MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "and"

Phrase: "class II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441886:Class II [Intellectual Product]
  1000   C2698968:Class II [Finding]

Phrase: "or"

Phrase: "an isotypic control IgG on the cytotoxicity of CTLs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0020854:IgG(T) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1115671:Lymphocytes.IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "from patients 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.100: Data are expressed as the meanSEM of 4independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the meanSEM of 4independent experiments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.101: To determine MHC restriction of these Id-specific CTL lines, we studied the inhibitory effect of anti-HLA antibodies on their cytolysis activity. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "MHC restriction of these Id-specific CTL lines,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0024518:Major Histocompatibility Complex [Gene or Genome]
   770   C1753349:Major histocompatibility complex [Cell Component]
   736   C0019627:Histocompatibility [Qualitative Concept]
   736   C0205164:Major [Qualitative Concept]
   736   C0439855:Complex [Qualitative Concept]
   736   C0443288:Restriction [Functional Concept]
   736   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the inhibitory effect of anti-HLA antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "on their cytolysis activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.102: Blocking MHC class I (HLA-ABC) or class II (HLA-DR) molecules of the target cells resulted in an inhibition of the cytotoxicity of the Id-specific CTL against Id-pulsed DCs (Figure 3C). 

Phrase: "Blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "(HLA-ABC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   756   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "class II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441886:Class II [Intellectual Product]
  1000   C2698968:Class II [Finding]

Phrase: "(HLA-DR"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
  1000   C0019764:Human leucocyte antigen DR [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   812   C0003320:Antigen [Immunologic Factor]
   812   C0023516:Leucocyte [Cell]
   812   C0031831:DR [Professional or Occupational Group]
   812   C0086418:Human [Human]
   812   C1707664:DR [Biomedical or Dental Material]
   812   C2348314:Dr. [Conceptual Entity]
   812   C3540849:DR [Idea or Concept]
   712 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: ")"

Phrase: "molecules of the target cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0567416:molecules [Substance]
   756   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]

Phrase: "resulted in an inhibition of the cytotoxicity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "of the Id-specific CTL"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T lymphocyte [Cell]
   840   C0039194:T-Lymphocyte [Cell]
   804   C0024264:Lymphocyte [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "against Id-pulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.103: The result further confirmed that the immune epitopes within myeloma Id were presented in association with MHC class I and class II molecules of the patients. 

Phrase: "The result further"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1274040:Result [Functional Concept]
   861   C1546471:Result [Idea or Concept]
   861   C2825142:Result [Finding]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the immune epitopes within myeloma Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003316:Epitopes [Immunologic Factor]

Phrase: "were"

Phrase: "presented in association"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0449450:Presented [Idea or Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "with MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "and"

Phrase: "class II molecules of the patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0567416:molecules [Substance]
Processing 00000000.tx.104: Idiotype-specific cytotoxic T lymphocytes lyse primary myeloma plasma cells in vitro To evaluate whether the Id-specific immune response is relevant to a clinical antimyeloma effect, we examined whether Id-specific CTLs lysed autologous primary myeloma cells. 

Phrase: "Idiotype-specific cytotoxic T lymphocytes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "primary myeloma plasma cells in vitro To"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   818   C0032112:Plasma Cells [Cell]
   813   C0333843:Myeloma cell [Cell]
   795   C0007634:Cells [Cell]
   795   C0032105:Plasma [Body Substance]
   795   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "whether"

Phrase: "the Id-specific immune response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0683201:Specific immune response [Organ or Tissue Function]
   861   C0301872:Immune response [Organ or Tissue Function]
   812   C0439662:Immune [Functional Concept]
   812   C0871261:Response [Organism Attribute]
   812   C1704632:Response [Finding]
   812   C1706817:Response [Intellectual Product]
   812   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "relevant to a clinical antimyeloma effect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2347946:Relevant [Qualitative Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "whether"

Phrase: "Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "autologous primary myeloma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   827   C0333843:Myeloma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0026764:Myeloma [Neoplastic Process]
   812   C3282337:Cells [Cell]
   812   C3538749:Myeloma [Intellectual Product]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.105: Using the CTL lines generated from the patients as effector cells, significant killing of the autologous myeloma cells was observed (Figure 4A). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CTL lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   923   C0039195:Cytotoxic T lymphocyte [Cell]
   861   C0039194:T-Lymphocyte [Cell]
   812   C0024264:Lymphocyte [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   812   C1511636:cytotoxic [Functional Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "generated from the patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "as effector cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0312740:Effector Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "killing of the autologous myeloma cells"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   783   C0333843:cells myeloma [Cell]
   783   C0599733:cells killing [Cell Function]
   753   C0007634:Cells [Cell]
   753   C0026764:Myeloma [Neoplastic Process]
   753   C0162388:Killing [Social Behavior]
   753   C0439859:Autologous [Qualitative Concept]
   753   C3282337:Cells [Cell]
   753   C3538749:Myeloma [Intellectual Product]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1269647:Cell [Cell]
   719 E C1550555:kill [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Figure 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.106: No killing was noted when the allogeneic primary myeloma cells from the other patient or when the natural killer-sensitive target cells K562 were used as target cells (Figure 4B). 

Phrase: "No"

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "was"

Phrase: "noted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]

Phrase: "when"

Phrase: "the allogeneic primary myeloma cells from the"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   774   C0333843:cells myeloma [Cell]
   774   C3485979:Cells, Allogeneic [Cell]
   757   C0007634:THE CELL [Cell]
           Cells
   748   C0026764:Myeloma [Neoplastic Process]
   748   C3282337:Cells [Cell]
   748   C3538749:Myeloma [Intellectual Product]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "or"

Phrase: "when"

Phrase: "the natural killer-sensitive target cells K562"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1517631:K562 [Cell]
   719   C0022688:Natural Killer Cells [Cell]
   719   C2363836:Natural Killer Cells [Laboratory Procedure]

Phrase: "were"

Phrase: "used as target cells"
Meta Candidates (Total=13; Excluded=6; Pruned=0; Remaining=7)
   833   C0221284:Target cells [Cell]
   833   C3272919:Target Cells [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1273517:used [Finding]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]
   770   C3282337:Cells [Cell]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947944:Use [Intellectual Product]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(Figure 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.107: Blocking of HLA-ABC and, to a lesser extent, HLA-DR molecules of the target cells inhibited the cytotoxicity of the CTLs (Figure 4C). 

Phrase: "Blocking of HLA-ABC"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0019629:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0019630:Human Leukocyte Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0019721:Human leucocyte antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
           leukocyte antigen
   753   C0003320:Antigen [Immunologic Factor]
   753   C0023516:Leucocyte [Cell]
   753   C0086418:Human [Human]
   753   C0233660:Blocking [Mental or Behavioral Dysfunction]
   753   C0332206:Blocking [Functional Concept]
   719 E C0028778:Block [Pathologic Function]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "to a lesser extent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]

Phrase: "HLA-DR molecules of the target cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0567416:molecules [Substance]
   720   C1513403:Molecular Target [Chemical Viewed Functionally,Chemical Viewed Structurally]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the cytotoxicity of the CTLs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   769   C0039195:Cytotoxic T-Lymphocytes [Cell]
   757   C0301896:Lymphocyte Cytotoxicity [Cell Function]
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "(Figure 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Thus, the results demonstrate that Id-specific CTLs are capable of mediating MHC-restricted cytotoxicity against the autologous primary myeloma cells and suggest that myeloma cells express, on their surfaces, T-cell epitopes derived from Id proteins in the context of MHC molecules. 

Phrase: "Thus,"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "are"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "MHC-restricted cytotoxicity against the autologous primary myeloma cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   701   C0022686:Cytotoxic cell [Cell]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: ","

Phrase: "on their surfaces,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205148:Surface [Spatial Concept]

Phrase: "T-cell epitopes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282580:T-Cell Epitopes [Immunologic Factor]
   827   C0003316:Epitopes [Immunologic Factor]
   734   C0039194:T-cell [Cell]

Phrase: "derived from Id proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]

Phrase: "in the context"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449255:Context [Finding]
  1000   C0542559:Context [Functional Concept]

Phrase: "of MHC molecules."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0567416:molecules [Substance]
   756   C0024518:Major Histocompatibility Complex [Gene or Genome]
   756   C1753349:Major histocompatibility complex [Cell Component]
   729 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.109: View larger version (27K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.110: Cytotoxicity of CTLs against primary tumor cells. 

Phrase: "Cytotoxicity of CTLs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   808   C0039195:Cytotoxic T-Lymphocytes [Cell]
   781   C0301896:Lymphocyte Cytotoxicity [Cell Function]
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "against primary tumor cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0677930:Primary Tumor [Neoplastic Process]
Processing 00000000.tx.111: (A) Cytotoxicity of CTL lines generated from patients 1() and 2() against the autologous primary myeloma plasma cells at different E:T ratios. 

Phrase: "(A) Cytotoxicity of CTL lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0301896:Lymphocyte Cytotoxicity [Cell Function]
   769   C0039195:Cytotoxic T lymphocyte [Cell]
   748   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")"

Phrase: "against the autologous primary myeloma plasma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   840   C0032112:Plasma Cells [Cell]
   836   C0333843:Myeloma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0032105:Plasma [Body Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "at different E:T ratios."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0456603:Ratios [Quantitative Concept]
   812   C1610540:*Ratios [Quantitative Concept]
   779 E C1547037:Ratio [Intellectual Product]
Processing 00000000.tx.112: (B) Comparison of cytotoxicity of CTL lines generated from patients 1() and 2() against the autologous primary myeloma plasma cells (Auto-PC) or the allogeneic myeloma plasma cells from the other patient (Allo-PC), or K562. 

Phrase: "(B) Comparison of cytotoxicity of CTL lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")"

Phrase: "against the autologous primary myeloma plasma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   840   C0032112:Plasma Cells [Cell]
   836   C0333843:Myeloma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0032105:Plasma [Body Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "(Auto-PC"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0007634:Cells [Cell]
   827   C0205225:Primary [Qualitative Concept]
   827   C0439631:Primary [Therapeutic or Preventive Procedure]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "the allogeneic myeloma plasma cells from the"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   788   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
   778   C0032112:Plasma Cells [Cell]
   774   C0333843:cells myeloma [Cell]
   774   C3485979:Cells, Allogeneic [Cell]
   757   C0007634:THE CELL [Cell]
           Cells
   748   C0032105:Plasma [Body Substance]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(Allo-PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "K562."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517631:K562 [Cell]
Processing 00000000.tx.113: E:T ratio was 20:1. 

Phrase: "E:T ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "20"

Phrase: ":"

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.114: (C) Inhibition by antibodies against MHC class I and class II or an isotypic control IgG on the cytotoxicity of CTLs from patients 1() and 2(). 

Phrase: "(C) Inhibition by antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "against MHC class I"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   884   C0024518:Major Histocompatibility Complex [Gene or Genome]
   884   C1753349:Major histocompatibility complex [Cell Component]
   853   C2245017:Complex I [Cell Component]
   840   C0441885:Class I [Classification]
   840   C2698967:Class I [Finding]
   804   C0019627:Histocompatibility [Qualitative Concept]
   804   C0021966:I- [Inorganic Chemical]
   804   C0205164:Major [Qualitative Concept]
   804   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0439855:Complex [Qualitative Concept]
   804   C0456387:Class [Intellectual Product]
   804   C1704241:Complex [Chemical Viewed Structurally]
   804   C1705943:Class [Classification]

Phrase: "and"

Phrase: "class II"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441886:Class II [Intellectual Product]
  1000   C2698968:Class II [Finding]

Phrase: "or"

Phrase: "an isotypic control IgG on the cytotoxicity of CTLs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0020854:IgG(T) [Amino Acid, Peptide, or Protein,Immunologic Factor]
   754   C1115671:Lymphocytes.IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "from patients 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.115: Data are expressed as the meanSEM of 3independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the meanSEM of 3independent experiments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.116: Cold target inhibition assay using CTLs from patient 2at an E:T ratio of 20:1, showing that (D) preincubation of CTLs with autologous Id-pulsed DCs (Auto-Id-DC) inhibited killing of labeled autologous primary cells (Auto-PC) and (E) preincubating with autologous primary cells inhibited the killing of labeled DCs pulsed with autologous Id proteins. 

Phrase: "Cold target inhibition assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CTLs from patient 2at"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0039195:Cytotoxic T-Lymphocytes [Cell]
   790   C0039194:T-Lymphocytes [Cell]
   753   C0024264:Lymphocytes [Cell]
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1511636:cytotoxic [Functional Concept]

Phrase: "an E:T ratio of 20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: ":"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "("

Phrase: "D)"

Phrase: "preincubation of CTLs"

Phrase: "with autologous Id-pulsed DCs (DCs)"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   911   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "killing of labeled autologous primary cells (Auto-PC)"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   783   C0599733:cells killing [Cell Function]
   753   C0007634:Cells [Cell]
   753   C0162388:Killing [Social Behavior]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0439859:Autologous [Qualitative Concept]
   753   C1708632:Labeled [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C0181496:Label [Manufactured Object]
   719 E C0681205:Kill [Idea or Concept]
   719 E C1269647:Cell [Cell]
   719 E C1550555:kill [Functional Concept]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and ("

Phrase: "E)"

Phrase: "preincubating with autologous primary cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0007634:Cells [Cell]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0439859:Autologous [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the"

Phrase: "killing of labeled DCs"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   806   C0011306:Dendritic Cells [Cell]
   797   C0599733:cells killing [Cell Function]
   773 E C0003315:Dendritic cell [Cell]
   773 E C1511762:Dendritic Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0011305:Dendritic [Cell Component]
   760   C0162388:Killing [Social Behavior]
   760   C0439640:Dendritic [Qualitative Concept]
   760   C1708632:Labeled [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0181496:Label [Manufactured Object]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550555:kill [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "pulsed with autologous Id proteins."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439859:Autologous [Qualitative Concept]
   760   C1947910:Pulsed [Phenomenon or Process]
   726 E C0232117:PULSE [Clinical Attribute]
   726 E C0391850:Pulse [Physiologic Function]
Processing 00000000.tx.117: Data are expressed as the meanSEM of 2independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the meanSEM of 2independent experiments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.118: To examine whether the same T cells mediated the killing of both the Id-pulsed DCs and primary myeloma cells, a cold target inhibition assay was performed. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "the same T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "the"

Phrase: "killing of both"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0162388:Killing [Social Behavior]
   756 E C0681205:Kill [Idea or Concept]
   756 E C1550555:kill [Functional Concept]

Phrase: "the Id-pulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary myeloma cells,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0333843:Myeloma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0026764:Myeloma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   827   C3538749:Myeloma [Intellectual Product]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "a cold target inhibition assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.119: In these experiments, CTLs were first incubated for 2hours at 37C with cold, unlabeled autologous DCs pulsed with the Id or the allogeneic Id proteins or with autologous primary tumor cells. 

Phrase: "In these experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "incubated for 2hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37C"

Phrase: "with cold,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009264:Cold [Natural Phenomenon or Process]
  1000   C0009443:Cold [Disease or Syndrome]
  1000   C0234192:Cold [Physiologic Function]

Phrase: "unlabeled autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   923   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the Id"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "or"

Phrase: "the allogeneic Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or with autologous primary tumor cells."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
   820   C1510985:Autologous Tumor Cells [Cell]
   790   C0431085:Tumor cells [Cell]
   790   C0677930:Primary Tumor [Neoplastic Process]
   756 E C0597032:Tumor Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205225:Primary [Qualitative Concept]
   753   C0439631:Primary [Therapeutic or Preventive Procedure]
   753   C0439859:Autologous [Qualitative Concept]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.120: As shown in Figure 4D, preincubation of CTLs with the autologous DCs pulsed with the Id, but not the allogeneic or isotype-matched Id proteins, led to diminished killing of the autologous 51Cr-labeled primary tumor cells. 

Phrase: "As"

Phrase: "shown in Figure 4D, preincubation of CTLs"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0039195:Cytotoxic T-Lymphocytes [Cell]
   764   C0039194:T-Lymphocytes [Cell]
   742   C0024264:Lymphocytes [Cell]
   742   C0450377:4d [Intellectual Product]
   742   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   742   C1511636:cytotoxic [Functional Concept]
   742   C2986754:4D [Temporal Concept]
   708   C1547282:Show [Intellectual Product]

Phrase: "with the autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the Id,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the allogeneic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515895:Allogeneic [Qualitative Concept]

Phrase: "or"

Phrase: "isotype-matched Id proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "led to diminished"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0205216:Diminished [Quantitative Concept]
   790   C1708698:LED [Manufactured Object]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C1522538:Lead [Functional Concept]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "killing of the autologous 51Cr-labeled primary tumor cells."
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   784   C1510985:Autologous Tumor Cells [Cell]
   764   C0431085:Tumor cells [Cell]
   764   C0677930:Primary Tumor [Neoplastic Process]
   762   C0599733:cells killing [Cell Function]
   742   C0007634:Cells [Cell]
   742   C0027651:Tumor [Neoplastic Process]
   742   C0162388:Killing [Social Behavior]
   742   C0205225:Primary [Qualitative Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]
   742   C0439859:Autologous [Qualitative Concept]
   742   C1578706:Tumor [Intellectual Product]
   742   C1708632:Labeled [Qualitative Concept]
   742   C3273930:Tumor [Finding]
   742   C3282337:Cells [Cell]
   731 E C0597032:Tumor Cell [Cell]
   708 E C0181496:Label [Manufactured Object]
   708 E C0681205:Kill [Idea or Concept]
   708 E C1269647:Cell [Cell]
   708 E C1550555:kill [Functional Concept]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.121: On the other hand, incubation of CTLs with autologous, but not allogeneic, primary tumor cells first resulted in reduced lysis of the autologous Id-pulsed DCs (Figure 4E). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "incubation of CTLs"

Phrase: "with autologous,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439859:Autologous [Qualitative Concept]

Phrase: "but"

Phrase: "not allogeneic, primary tumor cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   875   C3485979:Cells, Allogeneic [Cell]
   840   C0431085:Tumor cells [Cell]
   806 E C0597032:Tumor Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "resulted in reduced lysis of the autologous Id-pulsed DCs"
Meta Candidates (Total=22; Excluded=7; Pruned=0; Remaining=15)
   772   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   756   C0011306:Dendritic Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C0011305:Dendritic [Cell Component]
   738   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   738   C0024348:Lysis [Pathologic Function]
   738   C0392756:Reduced [Qualitative Concept]
   738   C0439640:Dendritic [Qualitative Concept]
   738   C0439859:Autologous [Qualitative Concept]
   738   C1536403:lysis [Cell Function]
   738   C1947910:Pulsed [Phenomenon or Process]
   738   C3282337:Cells [Cell]
   722 E C0003315:Dendritic cell [Cell]
   722 E C1511762:Dendritic Cell [Cell]
   704 E C0232117:PULSE [Clinical Attribute]
   704 E C0391850:Pulse [Physiologic Function]
   704 E C1269647:Cell [Cell]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]
   704   C2825142:Result [Finding]

Phrase: "(Figure 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.122: These results indicate that the same T cells were responsible for the killing of both target cells. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the same T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "responsible for the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1273518:Responsible [Finding]

Phrase: "killing of both target cells."
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0221284:Target cells [Cell]
   806   C3272919:Target Cells [Laboratory Procedure]
   797   C0599733:cells killing [Cell Function]
   760   C0007634:Cells [Cell]
   760   C0162388:Killing [Social Behavior]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
   760   C3282337:Cells [Cell]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550555:kill [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.123: Idiotype-specific cytotoxic T lymphocyte response is mediated by the perforin exocytosis pathway To investigate whether the cytotoxic function of Id-specific CTLs was mediated by the FasL/Fas or perforin systems, we examined the effect of CMA and Brefeldin A, the selected inhibitors of perforin-mediated and Fas-mediated cytotoxicity,17 respectively. 

Phrase: "Idiotype-specific cytotoxic T lymphocyte response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0871261:Response [Organism Attribute]
   799   C1704632:Response [Finding]
   799   C1706817:Response [Intellectual Product]
   799   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "mediated by the perforin exocytosis pathway To"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0015283:Exocytosis [Cell Function]
   748   C0070410:perforin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C1418887:Perforin [Gene or Genome]
   748   C1704259:Pathway [Molecular Function]
   748   C1705987:Pathway [Conceptual Entity]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "the cytotoxic function of Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C1518062:Lymphocyte Function [Biomedical Occupation or Discipline]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "mediated by the FasL/Fas"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0253023:Fas-L [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1515370:Fas-L [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "or"

Phrase: "perforin systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the effect of CMA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Brefeldin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the selected inhibitors of perforin-mediated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0243077:inhibitors [Chemical Viewed Functionally]
   719 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "Fas-mediated cytotoxicity,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   755 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   755 E C1511636:cytotoxic [Functional Concept]

Phrase: "17 respectively."
Processing 00000000.tx.124: Treatment of the CTL lines with Brefeldin A induced less than 20% inhibition in the lytic activity of Id-specific CTLs (Figure 5), indicating that the Fas/FasL system was not the main pathway of cytotoxicity mediated by our Id-specific CTLs. 

Phrase: "Treatment of the CTL lines"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with Brefeldin A induced less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   812   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "than 20% inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "in the lytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "(Figure 5"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "the Fas/FasL system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the main pathway of cytotoxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "mediated by our Id-specific CTLs."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0039195:Cytotoxic T-Lymphocytes [Cell]
   770   C0039194:T-Lymphocytes [Cell]
   744   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0024264:Lymphocytes [Cell]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0205369:Specific [Qualitative Concept]
   744   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   744   C1511636:cytotoxic [Functional Concept]
   744   C1552740:specific [Intellectual Product]
Processing 00000000.tx.125: This result was supported by flow cytometry analysis showing low or absent FasL expression by the T cells (data not shown). 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "was"

Phrase: "supported by flow cytometry analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0016263:Flow Cytometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0806140:Flow [Natural Phenomenon or Process]
   760   C0814048:Cytometry [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1521721:Supported [Conceptual Entity]
   760   C1524024:analysis [Functional Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205251:low [Qualitative Concept]
  1000   C1299352:Low [Qualitative Concept]
  1000   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "absent FasL expression by the T cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: In contrast, when we studied the inhibition of cytotoxicity by pretreatment with CMA, the cytolytic activity was almost completely abrogated (Figure 5). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "when"

Phrase: "we"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "the inhibition of cytotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with CMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347595:CMA [Occupation or Discipline]

Phrase: "the cytolytic activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "abrogated"

Phrase: "(Figure 5"

Phrase: ")."
Processing 00000000.tx.127: Treatment of the CTLs with Brefeldin A or CMA did not induce apoptosis in the cells (data not shown). 

Phrase: "Treatment of the CTLs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with Brefeldin A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "or"

Phrase: "CMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347595:CMA [Occupation or Discipline]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in the cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.128: Taken together, these results indicate that the cytotoxic function of Id-specific CTLs was mediated mainly by the perforin-dependent pathway. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the cytotoxic function of Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   745   C1518062:Lymphocyte Function [Biomedical Occupation or Discipline]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "mainly by the perforin-dependent pathway."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0070410:perforin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1418887:Perforin [Gene or Genome]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
   753   C3244310:dependent [Functional Concept]
Processing 00000000.tx.129: View larger version (12K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.130: Inhibition of CTL-mediated cytotoxicity against Id-pulsed DCs by the treatment of T cells with CMA or Brefeldin A. 

Phrase: "Inhibition of CTL-mediated cytotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "against Id-pulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "by the treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with CMA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347595:CMA [Occupation or Discipline]

Phrase: "or"

Phrase: "Brefeldin A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]
Processing 00000000.tx.131: CTLs tested are generated from patients 1() and 2(). 

Phrase: "CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "are"

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.132: Data are expressed as the meanSEM of 3independent experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as the meanSEM of 3independent experiments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.133: Cytokine production To characterize cytokine-secretion profile and its corresponding subsets of T cells, an ELISPOT assay was used to detect cytokine secretion. 

Phrase: "Cytokine production To"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1327413:cytokine production [Organism Function]
   827   C0033268:production [Occupational Activity]

Phrase: "characterize"

Phrase: "cytokine-secretion profile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1979963:Profile [Laboratory Procedure]
   827   C2003903:Profile [Functional Concept]
   734   C1327414:cytokine secretion [Cell Function]

Phrase: "and"

Phrase: "its corresponding subsets of T cells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0080202:T-Cell Subsets [Cell]
   804   C2362651:T cell subsets [Finding]
   719   C1515021:Subset [Classification]

Phrase: "an ELISPOT assay"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0920508:Enzyme-Linked Immunospot Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "cytokine secretion."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1327414:cytokine secretion [Cell Function]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
Processing 00000000.tx.134: As exemplified by the experiments depicted in Figure 6A-B, a small number of IFN- secreting cells was detected in the unstimulated T cells. 

Phrase: "As"

Phrase: "exemplified by the experiments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "depicted in Figure 6A-B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1553638:6a [Medical Device]

Phrase: "a small number of IFN- secreting cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "detected in the unstimulated T cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C0439819:Unstimulated [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.135: After rechallenge with Id-pulsed autologous DCs, elevated numbers of IFN-- and TNF--secreting cells were demonstrated. 

Phrase: "After rechallenge"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2347900:Rechallenge [Therapeutic or Preventive Procedure]
  1000   C3242312:re-challenge [Idea or Concept]

Phrase: "with Id-pulsed autologous DCs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   884   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "elevated numbers of IFN-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205250:Elevated [Qualitative Concept]
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]
   770   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C3163633:Elevated [Qualitative Concept]

Phrase: "-"

Phrase: "and"

Phrase: "TNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "--"

Phrase: "secreting cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "demonstrated."
Processing 00000000.tx.136: Levels of IL-4 secreting cells were extremely low or undetectable. 

Phrase: "Levels of IL-4 secreting cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C0456950:Level 4 [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "extremely low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "undetectable."
Processing 00000000.tx.137: Incubation with DCs only, or with DCs pulsed with the allogeneic Id protein from the other patient, did not significantly affect the number of cytokine-secreting cells. 

Phrase: "Incubation with DCs only,"

Phrase: "or with DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with the allogeneic Id protein"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1515895:Allogeneic [Qualitative Concept]
   753   C1947910:Pulsed [Phenomenon or Process]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C0391850:Pulse [Physiologic Function]

Phrase: "from the"

Phrase: "other patient,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "did"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the number of cytokine-secreting cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.138: These results were reproduced in the repeated experiments and indicate that the effector cells were of the type-1 T cells.20,21 View larger version (19K): [in this window] [in a new window]  Figure 6. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "reproduced in the repeated experiments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0205341:Repeated [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "indicate"

Phrase: "that"

Phrase: "the effector cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0312740:Effector Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were of the type-1 T cells.20,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   778   C0449475:Type of cell [Intellectual Product]
           cells type
   770   C0039194:T-Cells [Cell]
   770   C0441729:Type 1 [Classification]
   750 E C0007634:Cell Type [Cell]
           Cells
   744   C0332307:Type [Qualitative Concept]
   744   C1547052:*Type [Quantitative Concept]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "21 View larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 6."
Processing 00000000.tx.139: ELISPOT assay. 

Phrase: "ELISPOT assay."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0920508:Enzyme-Linked Immunospot Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]
Processing 00000000.tx.140: ELISPOT assay showing the number of cytokine-secreting cells per 104 CTLs generated from patients 1(A) and 2(B), in medium or induced by DCs pulsed with autologous Id (Auto-Id-DCs), allogeneic Id (Allo-Id-DCs), or unpulsed DCs (DCs). 

Phrase: "ELISPOT assay"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
  1000   C0920508:Enzyme-Linked Immunospot Assay [Laboratory Procedure]
   902   C2717977:Enzyme Assay [Laboratory Procedure]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the number of cytokine-secreting cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "per 104 CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0039195:Cytotoxic T-Lymphocytes [Cell]
   861   C0039194:T-Lymphocytes [Cell]
   812   C0024264:Lymphocytes [Cell]
   812   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   812   C1511636:cytotoxic [Functional Concept]

Phrase: "generated from patients 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]

Phrase: "(A)"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "in medium"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0009458:Medium [Intellectual Product]
   861   C0150312:In [Quantitative Concept]
   861   C0332285:In [Spatial Concept]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "or"

Phrase: "induced by DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0205263:Induced [Functional Concept]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "pulsed with autologous Id"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439859:Autologous [Qualitative Concept]
   770   C1947910:Pulsed [Phenomenon or Process]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C0391850:Pulse [Physiologic Function]

Phrase: "(Auto-Id-DCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0600091:ID [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "allogeneic Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Allo-Id-DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "unpulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   901   C0011306:Dendritic Cells [Cell]
   867 E C0003315:Dendritic cell [Cell]
   867 E C1511762:Dendritic Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0011305:Dendritic [Cell Component]
   827   C0439640:Dendritic [Qualitative Concept]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0011306:Dendritic Cells [Cell]
   966 E C0003315:Dendritic cell [Cell]
   966 E C1511762:Dendritic Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0011305:Dendritic [Cell Component]
   861   C0439640:Dendritic [Qualitative Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.141: Cytokines examined are IFN- (), TNF- (), and IL-4 ().  

Phrase: "Cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "are"

Phrase: "IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "("

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "IL-4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.142: Discussion Top Abstract Introduction Materials and methods Results Discussion References In this study, by using Id-pulsed DCs as APCs, we have generated autologous Id-specific CTL lines from patients with MM. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Id-pulsed DCs as APCs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   808   C0003315:Antigen-presenting dendritic cell [Cell]
       E   Dendritic cell
   770   C0011306:Dendritic Cells [Cell]
   744   C0007634:Cells [Cell]
   744   C0011305:Dendritic [Cell Component]
   744   C0439640:Dendritic [Qualitative Concept]
   744   C3282337:Cells [Cell]
   737 E C1511762:Dendritic Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "autologous Id-specific CTL lines from patients"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0039195:Cytotoxic T lymphocyte [Cell]
   764   C0039194:T-Lymphocyte [Cell]
   762   C0677856:Autologous Lymphocyte [Cell]
   742   C0024264:Lymphocyte [Cell]
   742   C0205132:lines [Spatial Concept]
   742   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   742   C1511636:cytotoxic [Functional Concept]
   708 E C1550648:Line [Substance]
   708 E C1552960:Line [Quantitative Concept]

Phrase: "with MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.143: These Id-specific CTLs were able to recognize and lyse not only autologous Id-pulsed DCs but also autologous primary myeloma plasma cells, justifying the exploration of Id-based immunotherapy in MM. 

Phrase: "These Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "recognize"

Phrase: "and"

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "not only autologous Id-pulsed DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   868   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   818   C0011306:Dendritic Cells [Cell]
   795   C0007634:Cells [Cell]
   795   C0011305:Dendritic [Cell Component]
   795   C0439640:Dendritic [Qualitative Concept]
   795   C3282337:Cells [Cell]
   785 E C0003315:Dendritic cell [Cell]
   785 E C1511762:Dendritic Cell [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "also autologous primary myeloma plasma cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   827   C0032112:Plasma Cells [Cell]
   822   C0333843:Myeloma cell [Cell]
   799   C0007634:Cells [Cell]
   799   C0032105:Plasma [Body Substance]
   799   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "justifying"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1552821:justify [Functional Concept]

Phrase: "the exploration of Id-based immunotherapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1280903:Exploration [Therapeutic or Preventive Procedure]

Phrase: "in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.144: Results observed in this study indicate that myeloma Id contains T-cell epitopes recognized by cells mediating proliferative and cytotoxic responses in an MHC-restricted manner. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "observed in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that myeloma Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "T-cell epitopes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0282580:T-Cell Epitopes [Immunologic Factor]
   827   C0003316:Epitopes [Immunologic Factor]
   734   C0039194:T-cell [Cell]

Phrase: "recognized by cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "proliferative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334094:Proliferative [Pathologic Function]

Phrase: "and"

Phrase: "cytotoxic responses in an MHC-restricted manner."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]
Processing 00000000.tx.145: Both the proliferative and the cytotoxic responses of the CTLs generated from 2patients were restricted by MHC class I and class II molecules, and the CTLs contained CD4+ and CD8+ T cells. 

Phrase: "Both"

Phrase: "the proliferative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334094:Proliferative [Pathologic Function]

Phrase: "and"

Phrase: "the cytotoxic responses of the CTLs"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "generated from 2patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "restricted by MHC class I"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   814   C0024518:Major Histocompatibility Complex [Gene or Genome]
   814   C1753349:Major histocompatibility complex [Cell Component]
   778   C0441885:Class I [Classification]
   778   C2698967:Class I [Finding]
   774   C2245017:Complex I [Cell Component]
   748   C0019627:Histocompatibility [Qualitative Concept]
   748   C0021966:I- [Inorganic Chemical]
   748   C0205164:Major [Qualitative Concept]
   748   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0439855:Complex [Qualitative Concept]
   748   C0443288:Restricted [Functional Concept]
   748   C0456387:Class [Intellectual Product]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1705943:Class [Classification]

Phrase: "and"

Phrase: "class II molecules,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]
   734   C0441886:Class II [Intellectual Product]
   734   C2698968:Class II [Finding]

Phrase: "and"

Phrase: "the CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8+ T cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   913   C0242629:cd8 cells [Cell]
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.146: The observation is in agreement with some previous studies showing that the Id produced by malignant B cells contains tumor-specific protein sequences that stimulated CD4+ and CD8+ T cells.23-29 Furthermore, the cytokine release by the CTLs was analyzed by the ELISPOT assay. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with some previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Id"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "produced by malignant B cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0004561:B-Cells [Cell]
   797   C0334227:Malignant cells [Cell]
   797   C2698007:Malignant Cells, NOS [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C0205282:Malignant [Qualitative Concept]
   760   C0334590:MALIGNANT [Neoplastic Process]
   760   C1533592:MALIGNANT [Neoplastic Process]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "tumor-specific protein sequences"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   875   C0260034:tumor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0002518:protein sequences [Amino Acid Sequence]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0162326:Sequences [Nucleotide Sequence]
   779 E C0004793:Sequence [Nucleotide Sequence]
   779 E C0162327:Sequence [Nucleotide Sequence]
   779 E C1519249:Sequence [Functional Concept]
   729 E C1548958:Sequential [Idea or Concept]
   729 E C1705294:Sequential [Qualitative Concept]

Phrase: "that stimulated CD4+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541261:CD4 [Laboratory Procedure]

Phrase: "and"

Phrase: "CD8+ T cells.23-29 Furthermore,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   839   C0242629:cd8 cells [Cell]
   827   C0039194:T-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0450348:23 [Quantitative Concept]
   799   C3282337:Cells [Cell]
   799   C3538720:CD8 [Laboratory Procedure]
   799   C3540595:CD8 [Gene or Genome]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "the cytokine release by the CTLs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "analyzed by the ELISPOT assay."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   853   C0920508:Enzyme-Linked Immunospot Assay [Laboratory Procedure]
   774   C2717977:Enzyme Assay [Laboratory Procedure]
   748   C0005507:Assay [Laboratory Procedure]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0243073:assay [Qualitative Concept]
   748   C0936012:Analyzed [Research Activity]
   748   C1510438:Assay [Laboratory Procedure]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]
Processing 00000000.tx.147: The production of a significant amount of IFN- and TNF- was observed when the CTLs were restimulated with Id-pulsed DCs. 

Phrase: "The production of a significant amount of IFN-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C3159140:interferon production [Organism Function]
   744   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "TNF-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "were"

Phrase: "restimulated with Id-pulsed DCs."
Meta Candidates (Total=14; Excluded=7; Pruned=0; Remaining=7)
   790   C0011306:Dendritic Cells [Cell]
   756 E C0003315:Dendritic cell [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C1947910:Pulsed [Phenomenon or Process]
   753   C3282337:Cells [Cell]
   719 E C0232117:PULSE [Clinical Attribute]
   719 E C0391850:Pulse [Physiologic Function]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.148: IL-4-secreting cells were extremely low or undetectable. 

Phrase: "IL-4-secreting cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "extremely low"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205251:low [Qualitative Concept]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "or"

Phrase: "undetectable."
Processing 00000000.tx.149: Thus, these results indicate that the Id-specific CTL lines contained type-1 CD4+ T-helper cell (Th1) and CD8+ CTL subsets,20,21 and both subsets may play important roles in the antimyeloma effects. 

Phrase: "Thus,"

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the Id-specific CTL lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0039195:Cytotoxic T lymphocyte [Cell]
   827   C0039194:T-Lymphocyte [Cell]
   799   C0024264:Lymphocyte [Cell]
   799   C0205132:lines [Spatial Concept]
   799   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   799   C1511636:cytotoxic [Functional Concept]
   766 E C1550648:Line [Substance]
   766 E C1552960:Line [Quantitative Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "type-1 CD4+ T-helper cell"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   929   C0242632:Type 1 T-helper cell [Cell]
           Type 1 helper cell
   895   C0449475:type cell [Intellectual Product]
   861   C0018894:T helper cell [Cell]
           Helper cell
   858   C0039215:cd4 cell [Cell]
   858   C3251824:CD4+ cell [Cell]
   799   C0007634:Cell [Cell]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "(Th1)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423842:TH1 [Gene or Genome]
  1000   C3540579:TH1 [Gene or Genome]

Phrase: "and"

Phrase: "CD8+ CTL subsets,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0080202:T-Lymphocyte Subsets [Cell]
   840   C0079720:Lymphocyte Subsets [Classification]
   840   C1304884:Lymphocyte subsets [Laboratory Procedure]
   771   C1515021:Subset [Classification]
   722   C0242629:CD8+ T-Lymphocyte [Cell]
           CD8 lymphocyte
   717   C0039195:Cytotoxic T lymphocyte [Cell]

Phrase: "20,"

Phrase: "21"

Phrase: "and"

Phrase: "both subsets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1515021:Subset [Classification]

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "important roles in the antimyeloma effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0035820:Roles [Social Behavior]
   719 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.150: Plasma cells represent the terminal differentiation stage of B-cell development. 

Phrase: "Plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0032112:Plasma Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the terminal differentiation stage of B-cell development."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   793   C1511002:B-Cell Differentiation [Cell Function]
   770   C2752630:terminal differentiation [Cell Function]
   767   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   767   C0205088:Terminal stage [Temporal Concept]
   767   C0441781:Stage B [Intellectual Product]
   744   C0205390:Stage [Temporal Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   744   C1511938:Differentiation [Clinical Attribute]
   744   C2945687:Differentiation [Functional Concept]
   731   C0870411:Developmental Stage [Temporal Concept]
Processing 00000000.tx.151: In MM, plasma cells constitute at least 10%, and can even reach more than 90%, of the total bone marrow cell count.22 One important aspect is whether the myeloma plasma cells can be recognized and regulated by tumor-specific T cells. 

Phrase: "In MM,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: "plasma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0032112:Plasma Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "constitute at least 10%,"

Phrase: "and"

Phrase: "can"

Phrase: "even"

Phrase: "reach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2584321:Reach [Organism Function]

Phrase: "more than 90%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205172:More [Functional Concept]
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]

Phrase: "of the total bone marrow cell count.22 One important aspect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C1547011:Aspect [Quantitative Concept]
   791   C1879746:Aspect [Qualitative Concept]

Phrase: "is"

Phrase: "whether"

Phrase: "the myeloma plasma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0032112:Plasma Cells [Cell]
   896   C0333843:Myeloma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "recognized"

Phrase: "and"

Phrase: "regulated by tumor-specific T cells."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   790   C0039194:T-Cells [Cell]
   783   C0431085:Tumor cells [Cell]
   767 E C0597032:Tumor Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0205369:Specific [Qualitative Concept]
   753   C0851285:Regulated [Governmental or Regulatory Activity]
   753   C1552740:specific [Intellectual Product]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.152: Our previous study has shown that freshly isolated primary myeloma cells can activate T cells; 

Phrase: "Our previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that freshly"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "primary myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C0333843:Myeloma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0026764:Myeloma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   827   C3538749:Myeloma [Intellectual Product]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.153: they stimulate alloreactive T cells and present recall antigens to autologous T cells,30 suggesting that myeloma cells can act as APCs. 

Phrase: "they"

Phrase: "stimulate"

Phrase: "alloreactive T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "present recall antigens to autologous T cells,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C0004359:Autologous Antigens [Immunologic Factor]
   771   C0487637:T-cell Antigen [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003320:Antigens [Immunologic Factor]
   748   C0034770:Recall [Mental Process]
   748   C1705180:Recall [Governmental or Regulatory Activity]
   748   C2361119:Recall [Clinical Attribute]

Phrase: "30"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "act as APCs."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   862   C0003315:Antigen-Presenting Cells [Cell]
   760   C0003320:Antigen [Immunologic Factor]
   760   C0007634:Cells [Cell]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0449450:Presenting [Idea or Concept]
   760   C3282337:Cells [Cell]
   726 E C0150312:Present [Quantitative Concept]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.154: The results of the current study demonstrate that Id-specific CTLs lyse the autologous plasma cells in an MHC-restricted manner, indicating that the tumor cells can process Id protein and present Id peptides in the context of MHC molecules on the cell surfaces. 

Phrase: "The results of the current study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0683954:results study [Finding]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that Id-specific CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0039195:Cytotoxic T-Lymphocytes [Cell]
   840   C0039194:T-Lymphocytes [Cell]
   804   C0024264:Lymphocytes [Cell]
   804   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   804   C1511636:cytotoxic [Functional Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "the autologous plasma cells in an MHC-restricted manner,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   756   C0032112:Plasma Cells [Cell]
   738   C0007634:Cells [Cell]
           THE CELL
   738   C0032105:Plasma [Body Substance]
   738   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   738   C3282337:Cells [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "indicating"

Phrase: "that"

Phrase: "the tumor cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0431085:Tumor cells [Cell]
   966 E C0597032:Tumor Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0027651:Tumor [Neoplastic Process]
   861   C1578706:Tumor [Intellectual Product]
   861   C3273930:Tumor [Finding]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "process Id protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0033666:process protein [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "present Id peptides in the context of MHC molecules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "on the cell surfaces."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0699040:Cell surface [Cell Component]
   827   C0205148:Surface [Spatial Concept]
Processing 00000000.tx.155: Taken together, these findings indicate that myeloma plasma cells express tumor antigens on their surfaces and are susceptible to tumor-specific, T cell-mediated lysis. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "indicate"

Phrase: "that myeloma plasma cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   901   C0032112:Plasma Cells [Cell]
   896   C0333843:Myeloma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "express"

Phrase: "tumor antigens on their surfaces"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0041361:Tumor Antigens [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781   C0003339:Surface Antigens [Immunologic Factor]
   760   C0003320:Antigens [Immunologic Factor]
   760   C0027651:Tumor [Neoplastic Process]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]

Phrase: "and"

Phrase: "are"

Phrase: "susceptible to tumor-specific, T cell-mediated lysis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0231204:Susceptible [Functional Concept]
   744   C2827758:SUSCEPTIBLE [Laboratory or Test Result]
Processing 00000000.tx.156: Because we used CTL lines in the current study that might have contained T cells with different specificity, it was important to examine whether the same T cells lysed both Id-pulsed DCs and primary tumor cells. 

Phrase: "Because"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CTL lines in the current"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   814   C0039195:Cytotoxic T lymphocyte [Cell]
   778   C0039194:T-Lymphocyte [Cell]
   748   C0024264:Lymphocyte [Cell]
   748   C0205132:lines [Spatial Concept]
   748   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   748   C1511636:cytotoxic [Functional Concept]
   714 E C1550648:Line [Substance]
   714 E C1552960:Line [Quantitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "that"

Phrase: "might"

Phrase: "have"

Phrase: "contained T cells with different specificity,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   804   C1136159:T-Cell Specificity [Molecular Function]
   790   C0039194:T-Cells [Cell]
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "it"

Phrase: "was"

Phrase: "important to"

Phrase: "examine"

Phrase: "whether"

Phrase: "the same T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "both Id-pulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary tumor cells."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   901   C0431085:Tumor cells [Cell]
   867 E C0597032:Tumor Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   734   C0677930:Primary Tumor [Neoplastic Process]
Processing 00000000.tx.157: As shown by the results of cold target inhibition experiments in Figure 4, it is clear that preincubation of the CTLs with Id-pulsed DCs inhibited the killing of primary tumor cells and vice versa. 

Phrase: "As"

Phrase: "shown by the results of cold target inhibition experiments"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   742   C0009264:Cold [Natural Phenomenon or Process]
   742   C0009443:Cold [Disease or Syndrome]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0234192:Cold [Physiologic Function]
   742   C0681814:Experiments [Research Activity]
   742   C1521840:Target [Functional Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
   742   C3463820:Inhibition [Activity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C1547282:Show [Intellectual Product]
   708 E C1706386:Experiment [Conceptual Entity]
   708   C2825142:Result [Finding]
           Experimental Result

Phrase: "in Figure 4,"

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that preincubation of the CTLs"

Phrase: "with Id-pulsed DCs"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the"

Phrase: "killing of primary tumor cells"
Meta Candidates (Total=17; Excluded=6; Pruned=0; Remaining=11)
   806   C0431085:Tumor cells [Cell]
   806   C0677930:Primary Tumor [Neoplastic Process]
   797   C0599733:cells killing [Cell Function]
   773 E C0597032:Tumor Cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0027651:Tumor [Neoplastic Process]
   760   C0162388:Killing [Social Behavior]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C1578706:Tumor [Intellectual Product]
   760   C3273930:Tumor [Finding]
   760   C3282337:Cells [Cell]
   726 E C0681205:Kill [Idea or Concept]
   726 E C1269647:Cell [Cell]
   726 E C1550555:kill [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "vice versa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814670:vice [Idea or Concept]
Processing 00000000.tx.158: Thus, we can conclude that the same T cells mediated the killing. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "can"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the same T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0039194:T-Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "the killing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
Processing 00000000.tx.159: This is an important issue because it indicates that by using the same Id proteins to vaccinate patients, the generation of a strong CTL response against the Id proteins could lead to tumor destruction. 

Phrase: "This"

Phrase: "is"

Phrase: "an important issue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033213:Issue [Finding]
   861   C1706387:Issue [Intellectual Product]

Phrase: "because"

Phrase: "it"

Phrase: "indicates"

Phrase: "that by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same Id proteins to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "vaccinate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1116171:vaccinate [Finding]

Phrase: "patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "the generation of a strong CTL response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0079411:Generation [Temporal Concept]
   742   C3146294:Generation [Activity]

Phrase: "against the Id proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "could"

Phrase: "lead to tumor destruction."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C1446301:Tumor destruction [Therapeutic or Preventive Procedure]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0027651:Tumor [Neoplastic Process]
   770   C1261381:Destruction [Therapeutic or Preventive Procedure]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1948029:Destruction [Activity]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3273930:Tumor [Finding]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.160: Our results also demonstrate that the immune response may be directly against the idiotypic determinants because the T cells responded only to the autologous Id protein, not to the allogeneic or isotype-matched Id proteins. 

Phrase: "Our results also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the immune response"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0301872:Immune response [Organ or Tissue Function]
   861   C0439662:Immune [Functional Concept]
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "may"

Phrase: "be"

Phrase: "directly against the idiotypic determinants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1947931:Directly [Qualitative Concept]
   726   C1521761:Determinant [Functional Concept]

Phrase: "because"

Phrase: "the T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "responded"

Phrase: "only to the autologous Id protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205171:Only [Quantitative Concept]
   753   C0439859:Autologous [Qualitative Concept]
   753   C1720467:Only [Intellectual Product]

Phrase: "not to the allogeneic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1515895:Allogeneic [Qualitative Concept]
   770   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "isotype-matched Id proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.161: Furthermore, we and others11,28,29 have shown that T-cell responses induced by Id proteins also were against synthetic peptides corresponding to the complementarity-determining region I-III of the Id proteins. 

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "and"

Phrase: "others11,"

Phrase: "28,"

Phrase: "29"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that T-cell responses"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]
   734   C0039194:T-cell [Cell]

Phrase: "induced by Id proteins also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021013:Idiotype [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205263:Induced [Functional Concept]

Phrase: "were against synthetic peptides"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   770   C1883254:synthetic [Activity]

Phrase: "corresponding to the complementarity-determining region I-III"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0887926:Complementarity Determining Region I [Amino Acid, Peptide, or Protein,Immunologic Factor]
   822   C0887928:Complementarity Determining Region III [Amino Acid, Peptide, or Protein,Immunologic Factor]
   800   C0021024:Complementarity-Determining Region [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0017446:Region [Geographic Area]
   744   C0021966:I- [Inorganic Chemical]
   744   C0205147:Region [Spatial Concept]
   744   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0439070:III [Intellectual Product]
   744   C1705160:III [Qualitative Concept]

Phrase: "of the Id proteins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.162: CTL recognition of target cells through their T-cell receptors activates 2distinct mechanisms of cell lysis.31,32 The first is granule exocytosis mediated by the pore-forming perforin and granzyme A and B.

Phrase: "CTL recognition of target cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0678836:cell recognition [Cell Function]
   748   C0524637:Recognition [Mental Process]

Phrase: "through their T-cell receptors"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0034790:T-Cell Receptors [Amino Acid, Peptide, or Protein,Immunologic Factor,Receptor]
   901   C0039194:T-cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "2distinct mechanisms of cell lysis.31,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "32"

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "is"

Phrase: "granule exocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015283:Exocytosis [Cell Function]

Phrase: "mediated by the pore-forming perforin"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0070410:perforin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205431:Forming [Functional Concept]
   753   C1325742:Pore [Cell Component]
   753   C1418887:Perforin [Gene or Genome]
   753   C1522492:Forming [Functional Concept]
   719 E C0348078:Form [Qualitative Concept]
   719 E C0376315:Form [Manufactured Object]

Phrase: "and"

Phrase: "granzyme A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061877:granzyme A [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415379:GRANZYME A [Gene or Genome]
   861   C1333877:Granzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.163: The second involves interaction between the Fas ligand on effector cells and Fas molecules expressed on the target cells. 

Phrase: "The second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "involves"

Phrase: "interaction between the Fas ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "on effector cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   966   C0312740:Effector Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "Fas molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:molecules [Substance]
   777 E C1521991:Molecular [Qualitative Concept]

Phrase: "expressed on the target cells."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0221284:Target cells [Cell]
   806   C3272919:Target Cells [Laboratory Procedure]
   760   C0007634:Cells [Cell]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.164: In the current study, the cells appeared to lyse the target cells mainly through the perforin-mediated pathway because CMA, the selective blocking agent, induced 90% inhibition of cytotoxicity. 

Phrase: "In the current study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "the target cells mainly through the perforin-mediated pathway"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   764   C0221284:Target cells [Cell]
   764   C3272919:Target Cells [Laboratory Procedure]
   745   C0007634:THE CELL [Cell]
           Cells
   742   C1521840:Target [Functional Concept]
   742   C2986546:TARGET [Diagnostic Procedure]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "because"

Phrase: "CMA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347595:CMA [Occupation or Discipline]

Phrase: "the selective blocking agent,"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   827   C0233660:Blocking [Mental or Behavioral Dysfunction]
   827   C0332206:Blocking [Functional Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]
   793 E C0028778:Block [Pathologic Function]
   793 E C1533157:Block [Substance]
   793 E C1706084:Block [Geographic Area]
   793 E C2828370:Block [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "90% inhibition of cytotoxicity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.165: Brefeldin A, a selective inhibitor of the Fas-mediated pathway, resulted in less than 20% inhibition. 

Phrase: "Brefeldin A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0054036:Brefeldin A [Antibiotic,Organic Chemical]
   861   C0304089:Brefeldin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "a selective inhibitor of the Fas-mediated pathway,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "resulted in less"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "than 20% inhibition."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]
Processing 00000000.tx.166: Hence, these findings are in agreement with our previous study showing that myeloma-reactive allospecific T cells also lysed target cells through the perforin pathway33 and are of special importance in view of published results on Fas expression on myeloma cells. 

Phrase: "Hence,"

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "are in agreement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0680240:Agreement [Social Behavior]
   790   C1551058:Are [Quantitative Concept]

Phrase: "with our previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that myeloma-reactive allospecific T cells also lysed target cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   829   C0221284:cells target [Cell]
           Target cells
   807   C3272919:Target Cells [Laboratory Procedure]
   791   C1521840:Target [Functional Concept]
   791   C2986546:TARGET [Diagnostic Procedure]

Phrase: "through the perforin pathway33"

Phrase: "and"

Phrase: "are of special importance"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205555:Special [Qualitative Concept]
   770   C1551058:Are [Quantitative Concept]

Phrase: "in view of published results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "on Fas expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "on myeloma cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.167: Landowski et al34 have shown that Fas antigen point mutation was detected in 10% of patients' bone marrow samples. 

Phrase: "Landowski et al34"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that Fas antigen point mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0162735:Point Mutation [Cell or Molecular Dysfunction]
   812   C0026882:Mutation [Genetic Function]
   812   C1552961:Point [Quantitative Concept]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]
   812   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "detected in 10% of patients' bone marrow samples."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   783   C0438737:Bone marrow sample [Body Substance]
   770   C0005953:Bone Marrow [Tissue]
   744   C0030705:Patients [Patient or Disabled Group]
   744   C0086590:Marrow [Food]
   744   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   744   C0376152:Marrow [Body Part, Organ, or Organ Component]
   744   C0391978:Bone [Tissue]
   744   C0442726:Detected [Finding]
   744   C1266908:Bone [Body Part, Organ, or Organ Component]
   744   C1266909:Bone [Body System]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1546708:Marrow [Intellectual Product]
   739 E C1708973:Medullary Bone [Tissue]
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.168: The mutations were located in the cytoplasmic region involved in the transduction of an apoptotic signal and, thus, render the cells resistant to Fas-induced apoptosis. 

Phrase: "The mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "located in the cytoplasmic region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1183489:Cytoplasmic region [Cell Component]
   760   C0010834:Cytoplasmic [Cell Component]
   760   C0017446:Region [Geographic Area]
   760   C0205147:Region [Spatial Concept]
   760   C0521449:Cytoplasmic [Body Location or Region]

Phrase: "involved in the transduction of an apoptotic signal"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0037083:Signal Transduction [Cell Function]
   744   C1160185:transduction [Organism Function]
   744   C1314939:Involved [Functional Concept]
   744   C1516044:Apoptotic [Qualitative Concept]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: ","

Phrase: "thus,"

Phrase: "render"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "resistant to Fas-induced apoptosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332325:Resistant to [Functional Concept]
           Resistant
   760   C2827757:RESISTANT [Laboratory or Test Result]
Processing 00000000.tx.169: Furthermore, they found that myeloma cells induced to be drug resistant also became resistant to Fas-mediated apoptosis.35 Thus, the use of CTLs that are cytotoxic through the Fas-mediated pathway may be limited, but the pore-forming CTLs can be used for the treatment of drug-resistant myeloma. 

Phrase: "Furthermore,"

Phrase: "they"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that myeloma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0333843:Myeloma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0026764:Myeloma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   861   C3538749:Myeloma [Intellectual Product]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "drug resistant also"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C0332325:Resistant [Functional Concept]
   827   C1254351:Drug [Pharmacologic Substance]
   827   C2827757:RESISTANT [Laboratory or Test Result]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "became"

Phrase: "resistant to Fas-mediated apoptosis.35 Thus,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0332325:Resistant to [Functional Concept]
           Resistant
   748   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "the use of CTLs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1524063:Use of [Functional Concept]
   753   C0042153:use [Functional Concept]
   753   C0457083:Use [Functional Concept]
   753   C1947944:Use [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "cytotoxic through the Fas-mediated pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   753   C1511636:cytotoxic [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "but"

Phrase: "the pore-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1325742:Pore [Cell Component]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "CTLs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0039195:Cytotoxic T-Lymphocytes [Cell]
   901   C0039194:T-Lymphocytes [Cell]
   827   C0024264:Lymphocytes [Cell]
   827   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   827   C1511636:cytotoxic [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "used for the treatment of drug-resistant myeloma."
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   767   C0449889:Drug used [Functional Concept]
   750 E C0242510:drug use [Mental or Behavioral Dysfunction]
   750   C1524063:Use of [Functional Concept]
   744   C0013227:Drug [Pharmacologic Substance]
   744   C0026764:Myeloma [Neoplastic Process]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C0332325:Resistant [Functional Concept]
   744   C1254351:Drug [Pharmacologic Substance]
   744   C1273517:used [Finding]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C2827757:RESISTANT [Laboratory or Test Result]
   744   C3538749:Myeloma [Intellectual Product]
   744   C3538994:TREATMENT [Research Activity]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.170: In conclusion, our results demonstrate that by using DCs as APCs, autologous Id-specific CTLs can be generated from myeloma patients. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DCs as APCs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   846   C0003315:Antigen-presenting dendritic cell [Cell]
       E   Dendritic cell
   790   C0011306:Dendritic Cells [Cell]
   756 E C1511762:Dendritic Cell [Cell]
   753   C0007634:Cells [Cell]
   753   C0011305:Dendritic [Cell Component]
   753   C0439640:Dendritic [Qualitative Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "autologous Id-specific CTLs"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   895   C0677856:autologous lymphocytes [Cell]
   895   C1711172:Autologous Lymphocytes [Cell]
   861   C0039195:Cytotoxic T-Lymphocytes [Cell]
   827   C0039194:T-Lymphocytes [Cell]
   799   C0024264:Lymphocytes [Cell]
   799   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   799   C1511636:cytotoxic [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "generated from myeloma patients."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026764:Myeloma [Neoplastic Process]
   770   C0030705:Patients [Patient or Disabled Group]
   770   C3146294:Generated [Activity]
   770   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.171: These T cells are efficient in killing Id-pulsed autologous DCs and primary myeloma cells from patients. 

Phrase: "These T cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0039194:T-Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "efficient in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0442799:Efficient [Qualitative Concept]
   761 E C0013682:Efficiency [Quantitative Concept]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "Id-pulsed autologous DCs"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   884   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   840   C0011306:Dendritic Cells [Cell]
   806 E C0003315:Dendritic cell [Cell]
   806 E C1511762:Dendritic Cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0011305:Dendritic [Cell Component]
   804   C0439640:Dendritic [Qualitative Concept]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "primary myeloma cells from patients."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   797   C0333843:cells myeloma [Cell]
   760   C0007634:Cells [Cell]
   760   C0026764:Myeloma [Neoplastic Process]
   760   C3282337:Cells [Cell]
   760   C3538749:Myeloma [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.172: Thus, our study provides strong and direct evidence to support the application of Id-based immunotherapies in MM.  

Phrase: "Thus,"

Phrase: "our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "strong"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442821:Strong [Qualitative Concept]
   928 E C0237897:Strength [Quantitative Concept]
   928 E C0808080:Strength [Idea or Concept]
   928 E C1705922:Strength [Qualitative Concept]

Phrase: "and"

Phrase: "direct evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the application of Id-based immunotherapies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in MM."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.173: Footnotes Submitted August 9,2000; 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825232:Footnote [Intellectual Product]

Phrase: "Submitted August 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515023:Submitted [Functional Concept]

Phrase: "2000"

Phrase: ";"
Processing 00000000.tx.174: accepted October 31,2000. 

Phrase: "accepted October 31,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450355:31 [Intellectual Product]
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2000."
Processing 00000000.tx.175: Supported in part by a grant from the Leukemia and Lymphoma Society. 

Phrase: "Supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "from the Leukemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023418:Leukaemia [Neoplastic Process]

Phrase: "and"

Phrase: "Lymphoma Society."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]
Processing 00000000.tx.176: Q.Y. is a recipient of the Leukemia and Lymphoma Society Translational Research Award. 

Phrase: "Q.Y."

Phrase: "is"

Phrase: "a recipient of the Leukemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709854:Recipient [Human]

Phrase: "and"

Phrase: "Lymphoma Society Translational Research Award."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0004446:Award [Manufactured Object]
Processing 00000000.tx.177: The publication costs of this article were defrayed in part by page charge payment. 

Phrase: "The publication"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034036:Publication [Intellectual Product,Manufactured Object]
  1000   C0034037:Publication [Occupational Activity]
  1000   C1704324:Publication [Intellectual Product]

Phrase: "costs of this article"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010186:Cost [Quantitative Concept]
   770   C0220812:Costs [Quantitative Concept]
   770   C1706852:Article [Intellectual Product]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by page charge payment."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0220808:payment [Quantitative Concept]
   827   C0680264:payment [Quantitative Concept]
Processing 00000000.tx.178: Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18U.S.C. section 1734. 

Phrase: "Therefore,"

Phrase: "and"

Phrase: "solely to"

Phrase: "indicate"

Phrase: "this fact,"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C. section 1734."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0205155:Section [Spatial Concept]
   804   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   804   C1522472:Section [Substance]
   804   C1552923:Section [Quantitative Concept]
   804   C1705191:Section [Physical Object]
Processing 00000000.tx.179: Reprints: Qing Yi, Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, 4301W Markham St, Slot 776,Little Rock, AR 72205; 

Phrase: "Reprints"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C3273171:Reprint [Intellectual Product]

Phrase: ":"

Phrase: "Qing Yi,"

Phrase: "Myeloma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026764:Myeloma [Neoplastic Process]
  1000   C3538749:Myeloma [Intellectual Product]

Phrase: "and"

Phrase: "Transplantation Research Center,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0683939:research center [Manufactured Object,Organization]
   827   C0205099:Center [Spatial Concept]

Phrase: "University of Arkansas for Medical Sciences,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0025118:medical sciences [Biomedical Occupation or Discipline]
   799   C0003790:Arkansas [Geographic Area]
   799   C0036397:Sciences [Occupation or Discipline]
   799   C0041740:University [Manufactured Object,Organization]
   799   C0205476:Medical [Functional Concept]
   799   C1551966:Arkansas [Language]

Phrase: "4301W Markham St,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3272372:ST [Intellectual Product]

Phrase: "Slot 776,"

Phrase: "Little Rock,"

Phrase: "AR 72205"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986463:AR+ [Finding]

Phrase: ";"
Processing 00000000.tx.180: e-mail: yiqing{at}exchange.uams.edu .  References Top Abstract Introduction Materials and methods Results Discussion References 1. 

Phrase: "e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "yiqing{at}exchange.uams.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.181: Alexanian R, Dimopoulos M. 

Phrase: "Alexanian R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dimopoulos M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.182: The treatment of multiple myeloma. 

Phrase: "The treatment of multiple myeloma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.183: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.184: 1994;7:484-489. 

Phrase: "1994"

Phrase: ";7"

Phrase: ":"

Phrase: "484-489."
Processing 00000000.tx.185: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.186: Barlogie B. 

Phrase: "Barlogie B."
Processing 00000000.tx.187: Plasma cell myeloma. 

Phrase: "Plasma cell myeloma."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0026764:Myeloma, Plasma-Cell [Neoplastic Process]
           Myeloma
   901   C0032112:Plasma cell [Cell]
   901   C0333843:cell myeloma [Cell]
   827   C0007634:Cell [Cell]
   827   C0032105:Plasma [Body Substance]
   827   C1269647:Cell [Cell]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   827   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.188: In: Beutler E,Lichtman M,Coller B,Kipps T, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Beutler E,Lichtman"

Phrase: "M,"

Phrase: "Coller B,Kipps T,"

Phrase: "eds."
Processing 00000000.tx.189: William's Hematology. 

Phrase: "William's Hematology."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   861   C0200627:HEMATOLOGY [Laboratory Procedure]
   789 E C0205488:Haematologic [Functional Concept]
Processing 00000000.tx.190: 5th ed. 

Phrase: "5th ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]
Processing 00000000.tx.191: New York: McGraw-Hill; 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "McGraw-Hill"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442532:Hill [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.192: 1995:1109-1126. 

Phrase: "1995"

Phrase: ":"

Phrase: "1109-1126."
Processing 00000000.tx.193: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.194: Attal M, Harousseau JC, Stoppa AM, et al. 

Phrase: "Attal M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Harousseau JC,"

Phrase: "Stoppa"

Phrase: "AM"

Phrase: ","

Phrase: "et al."
Processing 00000000.tx.195: A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. 

Phrase: "A prospective, randomized trial of autologous bone marrow transplantation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0008976:Trial [Research Activity]

Phrase: "and"

Phrase: "chemotherapy in multiple myeloma."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0013216:Chemotherapy [Therapeutic or Preventive Procedure]
   770   C0013217:chemotherapy [Functional Concept]
   770   C0392920:Chemotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.196: N Engl J Med. 

Phrase: "N Engl J Med."
Processing 00000000.tx.197: 1996;335:91-97[Abstract/Free FullText]. 

Phrase: "1996"

Phrase: ";335"

Phrase: ":"

Phrase: "91-97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.198: 4. 

Phrase: "4."
Processing 00000000.tx.199: Tricot G, Jagannath S, Vesole DH, Crowley J, Barlogie B. 

Phrase: "Tricot G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Jagannath S,"

Phrase: "Vesole DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Crowley J,"

Phrase: "Barlogie B."
Processing 00000000.tx.200: Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. 

Phrase: "Relapse of multiple myeloma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035020:Relapse [Phenomenon or Process]
   770   C0205336:relapse [Temporal Concept]
   770   C0277556:Relapse [Disease or Syndrome]

Phrase: "after autologous transplantation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]

Phrase: ":"

Phrase: "survival after salvage therapy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
Processing 00000000.tx.201: Bone Marrow Transplant. 

Phrase: "Bone Marrow Transplant."
Meta Candidates (Total=17; Excluded=5; Pruned=0; Remaining=12)
  1000   C0005961:Bone Marrow Transplant [Therapeutic or Preventive Procedure]
   913   C0005976:Bone transplant [Therapeutic or Preventive Procedure]
   901   C0005953:Bone Marrow [Tissue]
   827   C0040732:Transplant [Therapeutic or Preventive Procedure]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0332835:Transplant [Tissue]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]
Processing 00000000.tx.202: 1995;16:7-11[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";16"

Phrase: ":"

Phrase: "7-11"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.203: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.204: Kawakami Y, Eliyahu S, Jennings C, et al. 

Phrase: "Kawakami Y,"

Phrase: "Eliyahu S,"

Phrase: "Jennings C,"

Phrase: "et al."
Processing 00000000.tx.205: Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. 

Phrase: "Recognition of multiple epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0524637:Recognition [Mental Process]

Phrase: "in the human melanoma antigen gp100"

Phrase: "by tumor-infiltrating T lymphocytes"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   923   C0079722:Lymphocytes, Tumor-Infiltrating [Cell]
   923   C1515408:Tumor Infiltrating Lymphocytes [Pharmacologic Substance]
   861   C0039194:T-Lymphocytes [Cell]
   812   C0024264:Lymphocytes [Cell]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0332448:Infiltrating [Pathologic Function]
   812   C1578706:Tumor [Intellectual Product]
   812   C3273930:Tumor [Finding]
   779 E C1546677:Infiltrate [Intellectual Product]
   779 E C1549537:Infiltrate [Functional Concept]

Phrase: "associated with in vivo tumor regression."
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1515655:In Vivo [Spatial Concept]
           vivo
   790   C1718423:Tumor regression [Organism Attribute]
   753   C0027651:Tumor [Neoplastic Process]
   753   C0684320:Regression [Pathologic Function]
   753   C0684321:Regression [Mental Process]
   753   C1578706:Tumor [Intellectual Product]
   753   C3273930:Tumor [Finding]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.206: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.207: 1995;154:3961-3968[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";154"

Phrase: ":"

Phrase: "3961-3968"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.208: 6. 

Phrase: "6."
Processing 00000000.tx.209: Jager E, Chen YT, Drijfhout JW, et al. 

Phrase: "Jager E,"

Phrase: "Chen YT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412122:YT [Gene or Genome]

Phrase: "Drijfhout JW,"

Phrase: "et al."
Processing 00000000.tx.210: Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. 

Phrase: "Simultaneous humoral"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   789   C0020168:Humor [Intellectual Product]
   789   C0597811:humor [Therapeutic or Preventive Procedure]
   745 E C0683242:humorousness [Individual Behavior]

Phrase: "and"

Phrase: "cellular immune response against cancer-testis antigen NY-ESO-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   782   C1817908:Cellular Immune Response [Cell Function]
   760   C0301872:Immune response [Organ or Tissue Function]
   757   C1314973:antigen response [Clinical Attribute]
   739   C0007634:Cellular [Cell]
   739   C0178539:Cellular [Functional Concept]
   739   C0439662:Immune [Functional Concept]
   739   C0871261:Response [Organism Attribute]
   739   C1704632:Response [Finding]
   739   C1706817:Response [Intellectual Product]
   739   C2911692:Response [Mental Process]

Phrase: ":"

Phrase: "definition of human histocompatibility leukocyte antigen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1550452:definition [Idea or Concept]
   753   C1704788:Definition [Conceptual Entity]
   753   C3539107:Definition [Intellectual Product]

Phrase: "(HLA)-A2-binding peptide epitopes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0003316:Epitopes [Immunologic Factor]
   710   C0019733:Human leucocyte antigen A2 [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.211: J Exp Med. 

Phrase: "J Exp Med."
Processing 00000000.tx.212: 1998;187:265-270[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";187"

Phrase: ":"

Phrase: "265-270"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.213: 7. 

Phrase: "7."
Processing 00000000.tx.214: Hsu FJ, Caspar CB, Czerwinski D, et al. 

Phrase: "Hsu FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Caspar CB,"

Phrase: "Czerwinski D,"

Phrase: "et al."
Processing 00000000.tx.215: Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphomalong-term results of a clinical trial. 

Phrase: "Tumor-specific idiotype vaccines in the treatment of patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0376659:Vaccines, Tumor [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   742   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   708 E C1552558:Vaccine [Intellectual Product]

Phrase: "with B-cell lymphomalong-term"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1515273:Term [Temporal Concept]
   812   C1705313:Term [Idea or Concept]
   812   C2826302:TERM [Intellectual Product]

Phrase: "results of a clinical trial."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0008976:Clinical Trial [Research Activity]
           Trial
   806   C1096775:Clinical Trial [Intellectual Product]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
Processing 00000000.tx.216: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.217: 1997;89:3129-3135[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";89"

Phrase: ":"

Phrase: "3129-3135"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.218: 8. 

Phrase: "8."
Processing 00000000.tx.219: Rosenberg SA. 

Phrase: "Rosenberg SA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]
Processing 00000000.tx.220: Cancer vaccines based on the identification of genes encoding cancer regression antigens. 

Phrase: "Cancer vaccines"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0376659:Cancer Vaccines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0042210:Vaccines [Immunologic Factor,Pharmacologic Substance]
   827 E C1552558:Vaccine [Intellectual Product]

Phrase: "based on the identification of genes"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0017337:Genes [Gene or Genome]
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "cancer regression antigens."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0003320:Antigens [Immunologic Factor]
   734   C0920421:cancer regression [Neoplastic Process]
   721 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.221: Immunol Today. 

Phrase: "Immunol Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]
Processing 00000000.tx.222: 1997;18:175-182[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1997"

Phrase: ";18"

Phrase: ":"

Phrase: "175-182"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.223: 9. 

Phrase: "9."
Processing 00000000.tx.224: Kwak LW, Taub DD, Duffey PL, et al. 

Phrase: "Kwak LW,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1415842:LW [Gene or Genome]

Phrase: "Taub DD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538867:DD [Gene or Genome]

Phrase: "Duffey PL,"

Phrase: "et al."
Processing 00000000.tx.225: Transfer of myeloma idiotype-specific immunity from an actively immunized marrow donor. 

Phrase: "Transfer of myeloma idiotype-specific immunity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040671:Transfer [Mental Process]
   753   C1705822:Transfer [Activity]

Phrase: "from an actively immunized marrow donor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0013018:Donor [Population Group]
   812   C0040288:Donor [Population Group]
   812   C1527169:Donor NOS [Finding]
Processing 00000000.tx.226: Lancet. 

Phrase: "Lancet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]
Processing 00000000.tx.227: 1995;345:1016-1020[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1995"

Phrase: ";345"

Phrase: ":"

Phrase: "1016-1020"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.228: 10. 

Phrase: "10."
Processing 00000000.tx.229: Bergenbrant S, Yi Q, Osterborg A, et al. 

Phrase: "Bergenbrant S,"

Phrase: "Yi Q,"

Phrase: "Osterborg A,"

Phrase: "et al."
Processing 00000000.tx.230: Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients. 

Phrase: "Modulation of anti-idiotypic immune response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0678889:immune modulation [Organism Function]
   753   C0443264:Modulation [Spatial Concept]

Phrase: "by immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020971:Immunisation [Therapeutic or Preventive Procedure]
  1000   C0042196:immunisation [Therapeutic or Preventive Procedure]
  1000   C3244291:immunization [Functional Concept]

Phrase: "with the autologous M-component protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0700271:M Protein [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in multiple myeloma patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0026764:Multiple Myeloma [Neoplastic Process]
Processing 00000000.tx.231: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.232: 1996;92:840-846[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";92"

Phrase: ":"

Phrase: "840-846"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.233: 11. 

Phrase: "11."
Processing 00000000.tx.234: sterborg A, Yi Q, Henriksson L, et al. 

Phrase: "sterborg A,"

Phrase: "Yi Q,"

Phrase: "Henriksson L,"

Phrase: "et al."
Processing 00000000.tx.235: Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses. 

Phrase: "Idiotype immunization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020971:Immunisation [Therapeutic or Preventive Procedure]
   861   C0042196:immunisation [Therapeutic or Preventive Procedure]
   861   C3244291:immunization [Functional Concept]

Phrase: "combined with granulocyte-macrophage colony-stimulating factor"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   897   C0079460:Granulocyte-Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Colony-Stimulating Factor
   897   C0376563:Colony-Stimulating Factor, Granulocyte-Macrophage [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   897   C1149401:granulocyte macrophage colony-stimulating factor [Molecular Function]
   897   C1332791:GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [Gene or Genome]
   853   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   853   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   840   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   814   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0018183:granulocyte [Cell]
   748   C0024432:macrophage [Cell]
   748   C0205195:Combined [Qualitative Concept]
   748   C0439158:colony [Quantitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1947989:Colony [Cell]
   748   C1948023:Stimulating [Natural Phenomenon or Process]
   748   C2827422:Factor [Conceptual Entity]
   714 E C0336789:Combine [Manufactured Object]

Phrase: "in myeloma patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "type I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441729:Type I [Classification]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "major histocompatibility complex-restricted, CD8-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C3538720:CD8 [Laboratory Procedure]
   804   C3540595:CD8 [Gene or Genome]
   717   C0024518:Major Histocompatibility Complex [Gene or Genome]
   717   C1753349:Major histocompatibility complex [Cell Component]

Phrase: "and"

Phrase: "CD4-specific T-cell responses."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]
   708   C0039215:cd4 cell [Cell]
   708   C3251824:CD4+ cell [Cell]
Processing 00000000.tx.236: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.237: 1998;91:2459-2466[Abstract/Free FullText]. 

Phrase: "1998"

Phrase: ";91"

Phrase: ":"

Phrase: "2459-2466"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.238: 12. 

Phrase: "12."
Processing 00000000.tx.239: Wen YJ, Ling M, Bailey-Wood R, Lim SH. 

Phrase: "Wen YJ,"

Phrase: "Ling M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bailey-Wood R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Lim SH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]
Processing 00000000.tx.240: Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma. 

Phrase: "Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   857   C1321301:Peripheral Blood Mononuclear Cells [Cell]
           Peripheral blood mononuclear cell (cell)
   840   C0005773:Blood Cells [Cell]
   830   C0806987:Mononuclear cells [Cell]
   801   C0011306:Dendritic Cells [Cell]
   788   C0007634:Cells [Cell]
   788   C0011305:Dendritic [Cell Component]
   788   C0439640:Dendritic [Qualitative Concept]
   788   C3282337:Cells [Cell]
   768 E C0003315:Dendritic cell [Cell]
   768 E C1511762:Dendritic Cell [Cell]

Phrase: "prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "immune system in multiple myeloma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0020962:Immune system [Body System]
   806   C1291764:IMMUNE SYSTEM [Finding]
   760   C0439662:Immune [Functional Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
Processing 00000000.tx.241: Clin Cancer Res. 

Phrase: "Clin Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]
Processing 00000000.tx.242: 1998;4:957-962[Abstract]. 

Phrase: "1998"

Phrase: ";4"

Phrase: ":"

Phrase: "957-962"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.243: 13. 

Phrase: "13."
Processing 00000000.tx.244: Lim SH, Bailey-Wood R. 

Phrase: "Lim SH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]

Phrase: "Bailey-Wood R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.245: Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma. 

Phrase: "Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0042196:Vaccination [Therapeutic or Preventive Procedure]
Processing 00000000.tx.246: Int J Cancer. 

Phrase: "Int J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.247: 1999;83:215-222[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";83"

Phrase: ":"

Phrase: "215-222"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.248: 14. 

Phrase: "14."
Processing 00000000.tx.249: Reichardt VL, Okada CY, Liso A, et al. 

Phrase: "Reichardt VL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0228339:VL [Body Part, Organ, or Organ Component]
   861   C1424729:VL [Gene or Genome]
   861   C1858854:VL [Disease or Syndrome]

Phrase: "Okada CY,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0010622:CY [Geographic Area]
   861   C0332298:CY [Functional Concept]

Phrase: "Liso A,"

Phrase: "et al."
Processing 00000000.tx.250: Idiotypic vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma: a feasibility study. 

Phrase: "Idiotypic vaccination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042196:Vaccination [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dendritic cells after autologous peripheral blood stem cell transplantation"
Meta Candidates (Total=19; Excluded=6; Pruned=0; Remaining=13)
   810   C1518999:Peripheral Blood Stem Cells [Cell]
           Peripheral Stem Cells
   784   C0879593:autologous dendritic cells [Cell,Pharmacologic Substance]
   781   C1504389:cells stem transplantation [Therapeutic or Preventive Procedure]
   767   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   764   C0011306:Dendritic Cells [Cell]
   762   C0038250:Stem cells [Cell]
   762   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   742   C0007634:Cells [Cell]
   742   C0011305:Dendritic [Cell Component]
   742   C0439640:Dendritic [Qualitative Concept]
   742   C3282337:Cells [Cell]
   731 E C0003315:Dendritic cell [Cell]
   731 E C1511762:Dendritic Cell [Cell]
   717 E C2328697:Hemal cell [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "for multiple myeloma"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]

Phrase: ":"

Phrase: "a feasibility study."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015730:feasibility study [Intellectual Product,Research Activity]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
Processing 00000000.tx.251: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.252: 1999;93:2411-2419[Abstract/Free FullText]. 

Phrase: "1999"

Phrase: ";93"

Phrase: ":"

Phrase: "2411-2419"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.253: 15. 

Phrase: "15."
Processing 00000000.tx.254: Steinman RM. 

Phrase: "Steinman RM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]
Processing 00000000.tx.255: The dendritic cell system and its role in immunogenicity. 

Phrase: "The dendritic cell system"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1267794:Dendritic cell system [Body System]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]
   734   C0003315:Dendritic cell [Cell]
   734   C0011306:Dendritic cell [Cell]
   734   C1511762:Dendritic Cell [Cell]

Phrase: "and"

Phrase: "its role in immunogenicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.256: Ann Rev Immunol. 

Phrase: "Ann Rev Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.257: 1991;9:271-296[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1991"

Phrase: ";9"

Phrase: ":"

Phrase: "271-296"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.258: 16. 

Phrase: "16."
Processing 00000000.tx.259: Sallusto F, Lanzavecchia A. 

Phrase: "Sallusto F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lanzavecchia A."
Processing 00000000.tx.260: Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4and downregulated by tumor necrosis factor . J Exp Med. 

Phrase: "Efficient presentation of soluble antigen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0206431:Antigen Presentation [Cell Function]
   760   C0449450:Presentation [Idea or Concept]

Phrase: "by cultured human dendritic cells"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0427861:Human cells [Laboratory or Test Result]
   861   C0011306:Dendritic Cells [Cell]
   827 E C0003315:Dendritic cell [Cell]
   827 E C1511762:Dendritic Cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0011305:Dendritic [Cell Component]
   812   C0439640:Dendritic [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4and"
Meta Candidates (Total=21; Excluded=1; Pruned=0; Remaining=20)
   833   C0079460:Granulocyte-Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Colony-Stimulating Factor
   833   C0376563:Colony-Stimulating Factor, Granulocyte-Macrophage [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   833   C1149401:granulocyte macrophage colony-stimulating factor [Molecular Function]
   833   C1332791:GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR [Gene or Genome]
   806   C0079784:Macrophage Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   806   C1524095:macrophage colony-stimulating factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0079459:Granulocyte Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   782   C0009392:Colony-Stimulating Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0018183:granulocyte [Cell]
   739   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0024432:macrophage [Cell]
   739   C0332287:Plus [Qualitative Concept]
   739   C0439158:colony [Quantitative Concept]
   739   C1314677:Maintained [Functional Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C1947989:Colony [Cell]
   739   C1948023:Stimulating [Natural Phenomenon or Process]
   739   C2827422:Factor [Conceptual Entity]
   706 E C0024501:Maintain [Activity]

Phrase: "downregulated by tumor necrosis factor . J Exp Med."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   800   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   800   C1323304:tumor necrosis factor [Molecular Function]
   800   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0333516:Tumor necrosis [Neoplastic Process]
   770   C0760744:factor J [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0027540:Necrosis [Organ or Tissue Function]
   744   C0027651:Tumor [Neoplastic Process]
   744   C1334928:Necrosis [Finding]
   744   C1417055:EXP [Gene or Genome]
   744   C1521761:Factor [Functional Concept]
   744   C1578706:Tumor [Intellectual Product]
   744   C2827422:Factor [Conceptual Entity]
   744   C3273930:Tumor [Finding]
   731 E C1300818:Necrotic tumor [Neoplastic Process]
Processing 00000000.tx.261: 1994;179:1109-1118[Abstract]. 

Phrase: "1994"

Phrase: ";179"

Phrase: ":"

Phrase: "1109-1118"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.262: 17. 

Phrase: "17."
Processing 00000000.tx.263: Kataoka T, Shinohara N, Takayama H, et al. 

Phrase: "Kataoka T,"

Phrase: "Shinohara N,"

Phrase: "Takayama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "et al."
Processing 00000000.tx.264: Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin- and Fas-based lytic pathways in cell-mediated cytotoxicity. 

Phrase: "Concanamycin A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0056224:concanamycin A [Antibiotic,Organic Chemical]

Phrase: "a powerful tool for characterization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0336794:Power tool [Manufactured Object]
   760   C0336791:Tool [Manufactured Object]
   760   C2827396:Tool [Manufactured Object]

Phrase: "and"

Phrase: "estimation of contribution of perforin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0680844:estimation [Mental Process]
   760   C0681916:Estimation [Quantitative Concept]
   760   C0750572:Estimation [Quantitative Concept]

Phrase: "and"

Phrase: "Fas-based lytic pathways in cell-mediated cytotoxicity."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   835   C0301896:Cell-Mediated Cytotoxicity [Cell Function]
   793   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   721 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   721 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.265: J Immunol. 

Phrase: "J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.266: 1996;156:3678-3686[Abstract]. 

Phrase: "1996"

Phrase: ";156"

Phrase: ":"

Phrase: "3678-3686"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.267: 18. 

Phrase: "18."
Processing 00000000.tx.268: Yi Q, Bergenbrant S, sterborg A, et al. 

Phrase: "Yi Q,"

Phrase: "Bergenbrant S,"

Phrase: "sterborg A,"

Phrase: "et al."
Processing 00000000.tx.269: T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. 

Phrase: "T-cell stimulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]
   734   C0039194:T-cell [Cell]

Phrase: "induced by idiotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021013:idiotypes [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0205263:Induced [Functional Concept]

Phrase: "on monoclonal immunoglobulins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   966   C0443737:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   966   C0700271:Monoclonal immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021027:Immunoglobulins [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0202081:Immunoglobulins NOS [Laboratory Procedure]
   861   C0746619:monoclonal [Finding]
   827 E C1621846:immunoglobulin [Molecular Function]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with monoclonal gammopathies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1136085:Monoclonal Gammopathies [Neoplastic Process]
   966 E C0026470:monoclonal gammopathy [Neoplastic Process]
   861   C0178650:gammopathies [Disease or Syndrome]
   861   C0746619:monoclonal [Finding]
Processing 00000000.tx.270: Scand J Immunol. 

Phrase: "Scand J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.271: 1993;38:529-534[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";38"

Phrase: ":"

Phrase: "529-534"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.272: 19. 

Phrase: "19."
Processing 00000000.tx.273: Yi Q, sterborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK. 

Phrase: "Yi Q,"

Phrase: "sterborg A,"

Phrase: "Bergenbrant S,"

Phrase: "Mellstedt H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Holm G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lefvert AK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001905:AK [Geographic Area]
   861   C1412243:AK [Gene or Genome]
Processing 00000000.tx.274: Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. 

Phrase: "Idiotype-reactive T-cell subsets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0080202:T-Cell Subsets [Cell]
   884   C2362651:T cell subsets [Finding]
   771   C1515021:Subset [Classification]

Phrase: "and"

Phrase: "tumor load in monoclonal gammopathies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1449699:Tumor Load [Diagnostic Procedure]
   760   C1550025:Load [Idea or Concept]
   760   C1704782:Load [Manufactured Object]
   760   C1708715:Load [Activity]
Processing 00000000.tx.275: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.276: 1995;86:3043-3049[Abstract/Free FullText]. 

Phrase: "1995"

Phrase: ";86"

Phrase: ":"

Phrase: "3043-3049"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.277: 20. 

Phrase: "20."
Processing 00000000.tx.278: Mosmann TR, Sad S. 

Phrase: "Mosmann TR,"

Phrase: "Sad S."
Processing 00000000.tx.279: The expanding universe of T-cell subsets: Th1, Th2 and more. 

Phrase: "The expanding universe of T-cell subsets"

Phrase: ":"

Phrase: "Th1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423842:TH1 [Gene or Genome]
  1000   C3540579:TH1 [Gene or Genome]

Phrase: "Th2"

Phrase: "and"

Phrase: "more."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]
Processing 00000000.tx.280: Immunol Today. 

Phrase: "Immunol Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]
Processing 00000000.tx.281: 1996;17:138-146[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1996"

Phrase: ";17"

Phrase: ":"

Phrase: "138-146"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.282: 21. 

Phrase: "21."
Processing 00000000.tx.283: Cox FEG, Liew FY. 

Phrase: "Cox FEG,"

Phrase: "Liew FY."
Processing 00000000.tx.284: T-cell subsets and cytokines in parasitic infections. 

Phrase: "T-cell subsets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0080202:T-Cell Subsets [Cell]
  1000   C2362651:T cell subsets [Finding]
   793   C1515021:Subset [Classification]
   734   C0039194:T-cell [Cell]

Phrase: "and"

Phrase: "cytokines in parasitic infections."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.285: Immunol Today. 

Phrase: "Immunol Today."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0310367:Today [Antibiotic,Organic Chemical]
   861   C0750526:Today [Temporal Concept]
Processing 00000000.tx.286: 1992;13:445-448[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1992"

Phrase: ";13"

Phrase: ":"

Phrase: "445-448"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.287: 22. 

Phrase: "22."
Processing 00000000.tx.288: Kyle R. 

Phrase: "Kyle R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.289: Diagnostic criteria of multiple myeloma. 

Phrase: "Diagnostic criteria of multiple myeloma."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0679228:diagnostic criteria [Intellectual Product]
   760   C0243161:criteria [Intellectual Product]
Processing 00000000.tx.290: Hematol Oncol Clin North Am. 

Phrase: "Hematol Oncol Clin North"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1709269:North [Spatial Concept]

Phrase: "Am."
Processing 00000000.tx.291: 1992;6:347-358[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1992"

Phrase: ";6"

Phrase: ":"

Phrase: "347-358"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.292: 23. 

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.293: Bogen B, Weiss S. 

Phrase: "Bogen B,"

Phrase: "Weiss S."
Processing 00000000.tx.294: Processing and presentation of idiotypes to MHC-restricted T cells. 

Phrase: "Processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "presentation of idiotypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0449450:Presentation [Idea or Concept]

Phrase: "to MHC-restricted T cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   827   C0039194:T-Cells [Cell]
   799   C0007634:Cells [Cell]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.295: Int Rev Immunol. 

Phrase: "Int Rev Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.296: 1993;10:337-355[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";10"

Phrase: ":"

Phrase: "337-355"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.297: 24. 

Phrase: "24."
Processing 00000000.tx.298: Lauritzsen GF, Weiss S, Bogen B. 

Phrase: "Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Weiss S,"

Phrase: "Bogen B."
Processing 00000000.tx.299: Anti-tumor activity of idiotype-specific, MHC-restricted Th1 and Th2 clones in vitro and in vivo. 

Phrase: "Anti-tumor activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "of idiotype-specific, MHC-restricted Th1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C1423842:TH1 [Gene or Genome]
   795   C3540579:TH1 [Gene or Genome]

Phrase: "and"

Phrase: "Th2"

Phrase: "clones"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009013:Clone [Cell]
  1000   C1522642:Clone [Tissue]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.300: Scand J Immunol. 

Phrase: "Scand J Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.301: 1993;37:77-86[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";37"

Phrase: ":"

Phrase: "77-86"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.302: 25. 

Phrase: "25."
Processing 00000000.tx.303: Lauritzsen GF, Bogen B. 

Phrase: "Lauritzsen GF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0016703:GF [Geographic Area]
   861   C1551081:gf [Quantitative Concept]

Phrase: "Bogen B."
Processing 00000000.tx.304: The role of idiotype-specific CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. 

Phrase: "The role of idiotype-specific CD4+ T cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in tumor resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "against major histocompatibility complex class II molecule negative plasmacytoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   791   C0007634:Cells [Cell]
   791   C3282337:Cells [Cell]
   758 E C1269647:Cell [Cell]
   758 E C1704653:Cell [Medical Device]
   758 E C1948049:Cell [Spatial Concept]
   707   C0019630:Major Histocompatibility Complex Class II [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.305: Cell Immunol. 

Phrase: "Cell Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.306: 1993;148:177-188[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1993"

Phrase: ";148"

Phrase: ":"

Phrase: "177-188"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.307: 26. 

Phrase: "26."
Processing 00000000.tx.308: Dabadghao S, Bergenbrant S, Anton D, He W, Holm G, Yi Q. 

Phrase: "Dabadghao S,"

Phrase: "Bergenbrant S,"

Phrase: "Anton D,"

Phrase: "He W,"

Phrase: "Holm G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Yi Q."
Processing 00000000.tx.309: Anti-idiotypic T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells. 

Phrase: "Anti-idiotypic T-cell activation in multiple myeloma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1155065:T-Cell Activation [Cell Function]
   770   C1326120:cell activation [Cell Function]
   744   C1879547:Activation [Activity]

Phrase: "induced by M-component fragments"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0030490:M component [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0205263:Induced [Functional Concept]
   760   C0332255:fragments [Functional Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0449432:Component [Manufactured Object]
   760   C0486805:Fragments [Body Substance]
   760   C1705248:Component [Conceptual Entity]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "presented by dendritic cells."
Meta Candidates (Total=12; Excluded=6; Pruned=0; Remaining=6)
   833   C0011306:Dendritic Cells [Cell]
   799 E C0003315:Dendritic cell [Cell]
   799 E C1511762:Dendritic Cell [Cell]
   770   C0007634:Cells [Cell]
   770   C0011305:Dendritic [Cell Component]
   770   C0439640:Dendritic [Qualitative Concept]
   770   C0449450:Presented [Idea or Concept]
   770   C3282337:Cells [Cell]
   737 E C0150312:Present [Quantitative Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.310: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.311: 1998;100:647-654[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";100"

Phrase: ":"

Phrase: "647-654"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.312: 27. 

Phrase: "27."
Processing 00000000.tx.313: Yi Q, Eriksson I, He W, Holm G, Mellstedt H, sterborg A. 

Phrase: "Yi Q,"

Phrase: "Eriksson I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "He W,"

Phrase: "Holm G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mellstedt H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "sterborg A."
Processing 00000000.tx.314: Idiotype-specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4+ and CD8+ subsets. 

Phrase: "Idiotype-specific T lymphocytes in monoclonal gammopathies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0039194:T-Lymphocytes [Cell]
   748   C0024264:Lymphocytes [Cell]

Phrase: ":"

Phrase: "evidence for the presence of CD4+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "CD8+ subsets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515021:Subset [Classification]
Processing 00000000.tx.315: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.316: 1997;96:338-345[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1997"

Phrase: ";96"

Phrase: ":"

Phrase: "338-345"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.317: 28. 

Phrase: "28."
Processing 00000000.tx.318: Wen YJ, Ling M, Lim SH. 

Phrase: "Wen YJ,"

Phrase: "Ling M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lim SH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038108:SH [Geographic Area]
Processing 00000000.tx.319: Immunogenicity and cross-reactivity with idiotypic IgA of VH CDR3 peptide in multiple myeloma. 

Phrase: "Immunogenicity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0872192:immunogenic [Functional Concept]
   900 E C0003320:Immunogen [Immunologic Factor]

Phrase: "and"

Phrase: "cross-reactivity with idiotypic IgA of VH CDR3 peptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0010357:Cross Reactivity [Molecular Function]
   764   C0872139:cross reactivity [Molecular Function]
   764   C1880190:CROSS REACTIVITY [Event]
   742   C2828360:Cross [Conceptual Entity]

Phrase: "in multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.320: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.321: 1998;100:464-468[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1998"

Phrase: ";100"

Phrase: ":"

Phrase: "464-468"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.322: 29. 

Phrase: "29."
Processing 00000000.tx.323: Fagerberg J, Yi Q, Gigliotti D, et al. 

Phrase: "Fagerberg J,"

Phrase: "Yi Q,"

Phrase: "Gigliotti D,"

Phrase: "et al."
Processing 00000000.tx.324: T-cell epitope mapping of the idiotypic monoclonal IgG heavy and light chains in multiple myeloma. 

Phrase: "T-cell epitope mapping of the idiotypic monoclonal IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   764   C0242831:Epitope Mapping [Laboratory Procedure,Molecular Biology Research Technique]
   742   C1283195:Mapping [Activity]

Phrase: "heavy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439539:Heavy [Qualitative Concept]

Phrase: "and"

Phrase: "light chains in multiple myeloma."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0456844:Light chain myeloma [Neoplastic Process]
   760   C0023693:Light [Natural Phenomenon or Process]
   760   C0337112:chains [Manufactured Object]
   760   C1306462:Light [Functional Concept]
   760   C1524075:Chains [Idea or Concept]
   760   C1881376:Light [Qualitative Concept]
Processing 00000000.tx.325: Int J Cancer. 

Phrase: "Int J Cancer."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0006826:Cancer [Neoplastic Process]
   827   C0998265:Cancer [Eukaryote]
   827   C1306459:Cancer [Finding]
Processing 00000000.tx.326: 1999;80:671-680[CrossRef][Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1999"

Phrase: ";80"

Phrase: ":"

Phrase: "671-680"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.327: 30. 

Phrase: "30."
Processing 00000000.tx.328: Yi Q, Dabadghao S, sterborg A, Bergenbrant S, Holm G. 

Phrase: "Yi Q,"

Phrase: "Dabadghao S,"

Phrase: "sterborg A,"

Phrase: "Bergenbrant S,"

Phrase: "Holm G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.329: Myeloma bone marrow plasma cells: evidence for their capacity as antigen-presenting cells. 

Phrase: "Myeloma bone marrow plasma cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   888   C0005955:Bone Marrow Cells [Cell]
   881   C0333843:Myeloma cell [Cell]
   875   C0222677:Bone cells [Cell]
   867   C0545577:Marrow plasma cell [Cell]
   858 E C0029432:Bone cell [Cell]
   840   C0032112:Plasma Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0032105:Plasma [Body Substance]
   804   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "evidence for their capacity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332120:Evidence [Functional Concept]

Phrase: "as antigen-presenting cells."
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
  1000   C0003315:Antigen-Presenting Cells [Cell]
   827   C0003320:Antigen [Immunologic Factor]
   827   C0007634:Cells [Cell]
   827   C0449450:Presenting [Idea or Concept]
   827   C3282337:Cells [Cell]
   793 E C0150312:Present [Quantitative Concept]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   727 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.330: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.331: 1997;90:1960-1967[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "1960-1967"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.332: 31. 

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.333: Kagi D, Vignaux F, Ledermann B, et al. 

Phrase: "Kagi D,"

Phrase: "Vignaux F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ledermann B,"

Phrase: "et al."
Processing 00000000.tx.334: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. 

Phrase: "Fas"

Phrase: "and"

Phrase: "perforin pathways as major mechanisms of T cell-mediated cytotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1704259:Pathways [Molecular Function]
   739   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.335: Science. 

Phrase: "Science."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]
Processing 00000000.tx.336: 1994;265:528-530[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";265"

Phrase: ":"

Phrase: "528-530"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.337: 32. 

Phrase: "32."
Processing 00000000.tx.338: Kojima H, Shinohara N, Hanaoka S, et al. 

Phrase: "Kojima H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shinohara N,"

Phrase: "Hanaoka S,"

Phrase: "et al."
Processing 00000000.tx.339: Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. 

Phrase: "Two distinct pathways of specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704259:Pathways [Molecular Function]
   760   C1705987:Pathways [Conceptual Entity]

Phrase: "killing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:Killing [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "revealed by perforin mutant cytotoxic T lymphocytes."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0039195:Cytotoxic T-Lymphocytes [Cell]
   778   C0039194:T-Lymphocytes [Cell]
   748   C0024264:Lymphocytes [Cell]
   748   C0070410:perforin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0443289:Revealed [Qualitative Concept]
   748   C0596988:Mutant [Cell or Molecular Dysfunction]
   748   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   748   C1418887:Perforin [Gene or Genome]
   748   C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.340: Immunity. 

Phrase: "Immunity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020964:Immunity [Physiologic Function]
   928 E C0439662:Immune [Functional Concept]
Processing 00000000.tx.341: 1994;1:357-364[Medline] [OrderarticleviaInfotrieve]. 

Phrase: "1994"

Phrase: ";1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "357-364"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]."
Processing 00000000.tx.342: 33. 

Phrase: "33."
Processing 00000000.tx.343: Chiriva-Internati M, Du J, Cannon M, Barlogie B, Yi Q.

Phrase: "Chiriva-Internati M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Du J,"

Phrase: "Cannon M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barlogie B,"

Phrase: "Yi Q."
Processing 00000000.tx.344: Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells by the granule exocytosis pathway. 

Phrase: "Myeloma-reactive allospecific cytotoxic T lymphocytes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   876   C0200636:Reactive Lymphocytes [Laboratory Procedure]
   861   C0039195:Cytotoxic T-Lymphocytes [Cell]
   859 E C0221277:Reactive lymphocyte [Cell]
   827   C0039194:T-Lymphocytes [Cell]
   799   C0024264:Lymphocytes [Cell]
   799   C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   799   C1511636:cytotoxic [Functional Concept]

Phrase: "lyse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lyse [Pathologic Function]

Phrase: "target cells by the granule exocytosis pathway."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   778   C0221284:Target cells [Cell]
   778   C3272919:Target Cells [Laboratory Procedure]
   757   C0010837:Cell granule [Cell Component]
   757   C0596630:granule cell [Cell]
   748   C0007634:Cells [Cell]
   748   C1521840:Target [Functional Concept]
   748   C2986546:TARGET [Diagnostic Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.345: Br J Haematol. 

Phrase: "Br J Haematol."
Processing 00000000.tx.346: In press. 

Phrase: "In press."
Processing 00000000.tx.347: 34. 

Phrase: "34."
Processing 00000000.tx.348: Landowski TH, Qu N, Buyuksal I, Painter JS, Dalton WS. 

Phrase: "Landowski TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Qu N,"

Phrase: "Buyuksal I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Painter JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Dalton WS."
Processing 00000000.tx.349: Mutation in the Fas antigen in patients with multiple myeloma. 

Phrase: "Mutation in the Fas antigen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with multiple myeloma."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0026764:Multiple Myeloma [Neoplastic Process]
           Myeloma
   861   C0439064:Multiple [Quantitative Concept]
   861   C3538749:Myeloma [Intellectual Product]
Processing 00000000.tx.350: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.351: 1997;90:4266-4270[Abstract/Free FullText]. 

Phrase: "1997"

Phrase: ";90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ":"

Phrase: "4266-4270"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.352: 35. 

Phrase: "35."
Processing 00000000.tx.353: Landowski TH, Gleason-Guzman MC, Dalton WS. 

Phrase: "Landowski TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Gleason-Guzman MC,"

Phrase: "Dalton WS."
Processing 00000000.tx.354: Selection for drug resistance results in resistance to Fas-mediated apoptosis. 

Phrase: "Selection for drug resistance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036576:selection [Genetic Function]

Phrase: "results in resistance"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C0237834:Resistance [Mental Process]
   790   C1274040:Result [Functional Concept]
   790   C1514892:Resistance [Physiologic Function]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   718 E C0332325:Resistant [Functional Concept]
   718 E C1550464:resistent [Idea or Concept]
   718 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "to Fas-mediated apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.355: Blood. 

Phrase: "Blood."
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]
Processing 00000000.tx.356: 1997;89:1854-1861[Abstract/Free FullText].  

Phrase: "1997"

Phrase: ";89"

Phrase: ":"

Phrase: "1854-1861"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.357: 2001 by The American Society of Hematology.

Phrase: "2001 by The American Society of Hematology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   853   C1515949:American Society of Hematology [Professional Society]
   748   C0018943:Haematology NOS [Biomedical Occupation or Discipline]
   748   C0037455:society [Organization]
   748   C0200627:HEMATOLOGY [Laboratory Procedure]
   748   C0596070:American [Population Group]

